Малахов В. А., Завгородняя А. Н., Лычко В. С., Джанелидзе Т. Т., Волох Ф. А. Проблема оксида азота в неврологии харьков 2009

Скачать 3.75 Mb. Название Малахов В. А., Завгородняя А. Н., Лычко В. С., Джанелидзе Т. Т., Волох Ф. А. Проблема оксида азота в неврологии харьков 2009 страница 12/12 Дата 28.03.2013 Размер 3.75 Mb. Тип Документы

Содержание Проблема оксиду азоту в неврології

Crcager M.A., Gallagher S.J., Girerd X.J. et al. L-arginine improves endothelium-dependent vasodilation in hypercholcsterolcrnic humans. J. Clin. Invest., 1992: 90: 1242-1253. Crisby M. Modulation of the inflammatory process by statins. Timely Top Med Cardiovasc Dis. 2005 Mar 1; 9:E3. D’Hellencourt C.L., Montero-Menei C.N., Bernard R. and Couez D. (2003) J. Neurosci. Res., 71, 575-582. Daly C.A., Clemens F., Sendon J.L. et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina // Eur Heart J 2005; 26:996-1010. Danysz W., Parsons C.G., Mobius H.-J. et al. Neuroprotective and synptomatological action of memantine relevant for Alzheimer’s disease – A unified glutamatergic hypothesis on the mechanism of action // Neurotox. Res. 2000. Vol. 2. P. 85-97. Darius H. Role of nitrates for the therapy of coronary artery disease patients in the years be-yond 2000 // J Cardiovasc Pharmacol 1999 Aug; 34 Suppl 2:S15–20; discussion S 29-31. Davalos A., Fernandez-Real J.M., Ricart W. 1994. Stroke 24: 1543-1546. Davies K.J., Delsignore M.E., LinS.W. (1987) Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J. Biol. Chem., 262(20): 9902-9907. Davies M.G., Fulton G.J., Haggen P.O. // Brit. J. Surg. – 1995. – Vol. 82. – P. 1598-1610. Davies M.J., Thomas А.С. Plaque fissuring – the cause of acute myocardial infarction, sudden ischemic death, and creshendo angina. Brit. Heart Journ., 1985: 53: 363-373. Davis S.F., Yeung A.C., Meridith I.T. et al. Early endothelial dysfunction predicts the development ottransplant coronary artery disease at I year posttransplant. Circulation 1996; 93: 457-462. Dawson V., Dawson T., Bartley D. et al. Mechanisms of nitriс oxide mediated neurotoxicity in primary brain cultures. //J. Neurosci. – 1993. – Vol.13, №7. – P. 2651-2661. De Deyn P.P., Reuck J.D., Deberdt W., Vlietinck R., Orgogozo J.M. Stroke 1997 Dec;28(12):2347-52 De Graaf J.C., Banga J.D., Moncada S. et al. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation, 1992; 85: 2284-2290. De Leeuw F.-E., van Gijn J. Vascular dementia // Practical Neurology. 2003. Vol. 3. P. 86-91. De Maria F., Pedersen J.Z., CaccuriA. M. et al. // J. Biol. Chem. – 2003. – 278, N 43. – P. 42283-42293. De Groot M., Brecht M., Machicao F. Evidence for a factor protective against hypoxic parenchymal cell injury in a protein free blood extract // Res commun Cherm Pathol Pharmacol. 1990. V.68. P. 125-128. Del Zoppo G., Ginis I., Hallenbeck J.M., Iadecola C., Wang X., Feuerstein G.Z.. Brain Pathol 2000 Jan; 10(1): p95-112. Delbarre B., Delbarre G., Rochat C., Calinon F. Mol Chem Neuropathol 1995 Sep; 26(1):43-52. De Pace N., Herling I.M., Kotler M.N. et al. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action // Arch Intern Med 1982; 142:1806-1809. Desmond D.W. Vascular dementia // Clin. Neurosci. Res. 2004. Vol. 3. P. 437-448. Devuyst G., Bogousslavsky J. Recent progress in drug treatment for acute stroke // J. Neurol. Neurosurg. Psychiatr. 1999. Vol. 67. P. 420-425. Different plasma revels of nitric oxide in arterial and venous blood / E. Cicinelli [et al.] // Clin. Physiol. 1999. Vol. 19(5). P. 440-442. Ding, Y., Vaziri N. Nifedipine and Diltiazem but Not Verapamil Up-Regulate Endothelial Nitric Oxide Synthase Expression. J. Pharmacol. Exp. Ther. 2000; 292: 606-609. Dogan A., Eras M.A., Raghavendra Rao V.L., Dempsey R.J. Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats // Acta Neurochir. (Wien). 1999. Vol. 141. P. 1107-1113. Dohi Y., Criscione L., Pfeiffer K., Luscher T.F. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistence arteries. J. Cardiovasc Pharmacol 1994; 24:372-9. Drapier J-C. // Methods in Enzymology. – 1997. – 11. – P. 319-329. Drew В., Leluwenburch C. Ageing and the role of reactive nitrogen species. Ann N J Acad Sci 2002; 959:66-81. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial disfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet, 1991; 338: 1546-1550. Dugan L.L., Choi D.W. (1994) Excitotoxicity, free radicals and cell membrane changes. Ann. Neurol., 35(Suppl. S): 17-21. Dupuis J. Mechanisms of acute coronary syndromes and the potential role of statins. Atheroscler Suppl 2001; 2:9-14. Durzan D.J. // J. Forest Science. – 2002. – N 7. – P. 281-291. Dzau V.J., Gibbons G.H. Endothelium and growth factors in vascular remodelling of hypertension. Hypertension, 1991: 18 suppl. III: III-115-III-121. Eaton P., Jones M.E, McGregor M. et al. // J. Am. Soc. Nephrol. – 2003. – 14, N 3. – P. S290-S296. Eberly L.E., Neaton J.D., Thomas A.J. et al. Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial. Clin Trials. 2004; 1(2):148-161. Ebert B., Mikkelsen S., Thorkildsen C., Borgbjerg F.M. Eur J Pharmacol 1997 Aug 20; 333(1):99-104 Related Articles, Books. Eddahibi S., Adnot S., Corvil С. et al. L-arginine restores endothelium dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol Lung Cell Мої Physiol 1992; 263:L194-L200. Effect of mellitin on the Central Nervous System / I. Ishay [et al.] // Toxicol. 1975. Vol. 13(4). P. 277-283. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Inter-vention Trial in Congestive Heart Failure (MERIT-HF) // Lancet 1999; 353:2001-2007. Egashira K., Inou T., Hirooka Y., Yamada A. et al. Evidence of impaired endothclium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograins. New Engl. J. Mod. 1993; 328: 1659-1664. Ehrlich M., Knolle E., Ciovica R. et al. Memantine for prevention of spinal cord injury in a rabbit model // J. Thorac. Cardiovasc. Surg. 1999. Vol. 117. P. 285-291. Eide K., Stubhaug A., Oye I., Breivik H. Pain 1995 May; 61(2):221-228 Related Articles, Books, LinkOut Eiserich J.P., Hristova M., Cross С.E. et al. // Nature. – 1998. – 391, N 6665. – P. 393-397. Elkayam U., Johnson J.V., Shotan A. et al. Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition // Circulation 1999; 99:2652-2657. Elkayam U., Johnson J.V., Shotan A. et al. Intermittent large dose nitrates added to standard therapy, improves left ventricular function and exercise capacity in patients with chronic heart failure [abstr] // J Am Coll Cardiol 1999; 33:188A. Elkayam U., Weber L., McKay C., Rahimtoola S. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure // Am J Cardiol 1985; 56:560-566. Emanuelsson H., Ake H., Kristi M., Arina R. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris // Eur J Clin Phar-macol 1989; 36:561-565. Emerson M., Momi S., Paul W., Alberti P.F. et al. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. Thromb Haemost 1999; 81:961-966. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. 1998 Nature 391 (6662), 43-50. Erben R.G., Soegiarto D.W., Weber K., Zeitz U., Lieberherr M., Gniadecki R., Moller G., Adamski J. and Balling R. (2002) Mol. Endocrinol., 16, 1524-1537. Erkinjuntti T., Inzitari D., Pantoni L. еt al. Research criteria for subcortical vascular dementia in clinical trials // J. Neural. Transm. 2000. Suppl. 59. P. 23-30. Erkinjuntti T., Roman G., Gauthier S. et al. Emerging therapies for vascular dementia and vascular cognitive impairment // Stroke. 2004. Vol. 35. P. 1010-1017. Erkinjuntti T., Roman G., Gauthier S. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors // J Neurol Sci. 2004. Vol. 226. P. 63-66. Espey M.G., Miranda K.M., Feelisch M. et al. // Ann. N. Y. Acad. Sci. –2000. – 899. –P. 209-221. Esposito K., Nappo F., Giugliano G. еt al. Effect of dietary antioxidants on endothelial dysfunction induced by high-fat meel. Am J Clin Nutrition 2003; 77:l:139-143. Essing M., Nguyen G., Prie D. et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 1998; 83:683-90. EstevezA. G., Spear N., Manuel S. M. et al. // Ibid. – 1998. – 18, N 3. – P. 923-931. EstevezA. G., Joaquin J. // Ann. N.-Y. Acad. Sci. – 2002. – 962. – P. 207-211. Esther C.R.Jr., Marino E.M., Howard Т.Е. et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J. Clin. Invest. 1997: 99: 2375-2385. Eyles D., Brown J., Mackay-Sim A., McGrath J. and Feron F. (2003) Neurosci., 118, 641-653. Falk E., Shah P.K., Faster V. Coronary plaque disruption. Circulation, 1995; 92: 657-671. Farmer J.A., Gotto A.M. Jr. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol. 2003 Jul 3;92(1A):3i–9i. Fassbender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schutt S., Fritzinger M., Horn P., Vajkoczy P., Kreisel S., Brunner J., Schmiedek P, Hennerici M. J Neurol Neurosurg Psychiatry 2001 Apr; 70(4):534-537. Feigin V.L., Rinkel G.J., Algra A., Vermeulen M., van Gijn J. 2000. Cochrane Database Syst Rev 2000; (2):CD000277. Fenster С.Р., Weinster R.L., Darley-Usmar V.M., Palet R.P. Obesity, aerobic exercise and vascular disease: the role of oxidant stress. Obes Res 2002; 0:964-968. Ferdinandy P., Schulz R. Nitric oxide, superoxide and peroxinitrite in myocardial ischemia-reperfusion injury and preconditioning. Br J Pharmacol 2003. – 138, N 4. – Р. 532-543. Feron O., Dessy C., Desager J.P. et al. Hydroxy-methylglutarylconezyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 2001; 103:113-118. Ferro D, Basili S, Alessandri С et al. Inhibition of tissuefactor- mediated thrombin generation by simvastatin. Atherosclerosis 2000; 149:111-116. Figueras J., Lidon R., Cortadellas J. Rebound myocardial ischaemia following abrupt interruption of intra-venous nitroglycerin infusion in patients with unstable angina at rest // Eur Heart J 1991;12:405-411. Fike C.D., Kaplowitz M.R., Thomas C.J. et al. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lung. Am J Physiol Lung Cell Мої Physiol 1998; 274:L517-L526. Finnegan K.T. Neurosci.-N1.-P.14-19 – 1993. Flather M., Collinson J., Wright A., et al. 71 Practice patterns for patients with unstable angina and myocardial infarction without ST elevation: UK prospective registry of acute ischaemic syndromes (PRAIS-UK) // Lancet 1999; 353(Suppl 3):65. Folmar S., Oates-Williams F., Sharp P., Reboussin D., Smith J., Cheshire K., Macer J., Klein K.P., Herrington D. Recruitment of Participants for the Estrogen Replacement and Atherosclerosis (ERA) Trial. A Comparison of Costs, Yields and Participant Characteristics from Community- and Hospital-Based Recruitment Strategies. Control Clin Trials 2001; Feb; 22(1):13-25. Folstein M.F., S.E. Folstein, P.R. McHugh. Mini-Mental State: a practical guidefor grading the mental state of patients for the clinician // J Psych Res. 1975. V. 12. P. 189-198. Ford W.R., Clanachen A.S., Jugdutt B.I. Opposite effect of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat heats. Circulation. 1996; 94: 3087-3089. Forrete F., Seux M., Staessen J. et al. Prevention of dementia in randomized double blind placebo controlled Systolic hypertension in Europe (Syst-Eur trial) // Lancet. 1998. V. 352. P. 1347-1351. Fox K., Garcia M.A., Ardissino D. et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology // Eur Heart J 2006; 27:1341-1381. Franco O.H., Peeters A., Looman C.W. et al. Cost effectiveness of statins in coronary heart disease. J Epidemiol Community Health. 2005 Nov;59(11):927–933. Frank P.G., Woodman S.E., Park D.S., Lisanti M.P. // Arterioscler. Thromb. Vase. Biol. 2003. Vol. 23, N 7. P. 1161-1168. Freo U., Pizzolato G., Dam M. et al. A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials // J. Neural. Transm. 2002. Vol. 109. P. 857–870. Frisoni G.B., Galluzzi S., Bresciani L. еt al. Mild cognitive impairment with subcortical vascular features. Clinical characteristics and outcome // J. Neurol. 2002. Vol. 249. P. 1423–1432. Frohlich E.D., Tarazi R.C. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertropliy? Amer. J. Cardiol. 1979: 44: 959-963. Frohlich E.D. Overview of hemoilynamic factors associated with left ventricular hypertrophy. J. Mol. Cell. Cardiol., 1989: 21: 3-10. Fu C., Chute D.J., Farag E.S., Garakian J. et al. Comorbidity in dementia: an autopsy study // Arch Pathol Lab Med. 2004. Vol. 128. № 1. P. 32-38. Fujiwara N., Osanai T., Kamada T., Katoh T., Takahashi K., Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt in take Circulation 2000 Feb 29; 101(8):856-861. Fumiyuki Yamakura, Hikari Така, Tsutomu Fujimura, Kimie Murayama // J. Biol. Chem. —1998. – 273, N 23. – P. 14085-14089. Furchgott R.F., Zawadszki J.V. The obligatoryrole of endotnelial cells in the relazation of arterial smooth muscle by acetylcholine. Nature. 1980: 288: 373-376. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 1989; 3: 2007-2018. Fuster V., Lewis A. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation, 1994: 90: 2126-2146. Gahm C., Holmin S., Mathiesen T. Nitric oxide synthase expression after human brain contusion // Neurosurgery. – 2002. – Vol. 50. – P. 1319-1326. Gai H., Harrison D. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulat Res 2000; 87:840-844. Gammage M. Treatment of acute pulmonary oedema: diuresis or vasodilatation? // Lancet 1998; 351:382-388. Gammage M.D., Murray R.G., Littler W.A. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction // Eur J Clin Pharmacol 1986; 29:639-643. Garcion E., Nataf S., Berod A., Darcy F. and Brachet P. (1997) Brain Res. Mol. Brain. Res., 45, 255-267. Garcion E., Sindji L., Nataf S., Brachet P., Darcy F. and Montero-Menei, C.N. (2003) Acta Neuropathol., 105, 438-448. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion, D. (2002) Tr. Endocrinol. Metab., 13, 100-105. Garnett W. The pharmacology of fluvastatin. Clin. Cardiol., 1994; 17:3-10. Garthwaite J. Neural Nitric Oxide Signalling // Trends Neurosci. 1995. Vol. 18. P. 51-56. Gaut J. P., Byun J., Tran H. D. et al. // J. Clin. Invest. – 2002. – 109, N 10. – P. 1311-1319. Gerhard М., Walsh W., Tawakol А. et al. Estradiol Therapy Combined With Progesterone and Endothelium-Dependent Vasodilation in Postmenopausal Women. Circulation. 1998; 98:1158-1163. Geroldi C., Ferrucci L., Bandinelli S. et al. Mild cognitive deterioration with subcortical features: Prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study) // J. Amer. Ger. Soc. 2003. Vol. 51. P. 1064–1071. Gerova M. Nitric oxide compromised hypertension: facts and enigmas. Physiol Res 2000; 49:27-35. Ghadge G.D., Lee J.P., Bindokas V.P. et al. // J. Neurosci. – 1997. – 17, N 15. – P. 8756-8766. Giannone G., Takeda K, Kleschyov A.L. // J. Physiol. – 2000. – 529, N 3. – P. 735-745. Gibbons G.H., Dzau V.J. The emerging concept of vascular remodelling. New Engl. J. Med., 1994, 330: 1431-1438. Gillard S., Boyd T. // Lancet. – 1982. – Vol. 212, N 8. – P. 843-866. Giraldelo С.М., Zappellini A., Mascara M.N. et al. Effect of L-arginine anologues on rat hind paw oedema and mast cell activation in vitro. Eur J Pharmacol 1994;257:87-93. Giroud D., Li J.M., Urban P., Meier B., Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Amer. J. Cardiol. 1992; 69: 729-732. Giulian D., Corpuz M. J Neurosci Res. – N6. – P. 681-93-1993. Gladwin M.Т., Schechter A.N. // Circ. Res. – 2004. – 94, N 7. – P. 851-855. Glasser S.P. Effect of extended-release isosorbide mononitrate one hour after dosing in pa-tients with stable angina pectoris. IMDUR Study Group // Am J Cardiol 1997; 80(12):1546-1550. Gobel E.J., Hautvast R.W., van Gilst W.H. et al. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris // Lancet 1995; 346:1653-1657. Gohlke P., Pees C., Unger T. AT2-receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanisms. Hypertension. 1998; 3:349-355. Gohlke P., Zinz W., Scholkens B.A. et al. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 1996; 28:397-402. Goldstein R.E., Boccuzzi S.J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Ex-perience Committee; and the Multicenter Diltiazem Postinfarction Research Group // Circulation 1991;83:52-60. Golomb J., Kluger A., Ferris S.H., Garrand P. Clinician’s Manual on Mild Cognitive Impairment. London: Science Press, Ltd. 2001. P. 56. Gow A.J., Stamler J.S. // Nature. – 1998. – 391, N 6663. – P. 169-73. Green L.C., Davic A.W., Golawski J. et al. Analysis of nitrate, nitrite and nitrate in biological fluids // Anal. Biochem. – 1982. – Vol. 126, № 1. – P. 131-138. Greenberg D.A. (1987). Ann Neurol 21: 317-3. Griendling K.K., Minieri C.A., Ollerenshaw J.D. and Alexander R.W. Angiotensin 2 stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res.1994; 74:1141-1148. Griendling K.K., Ushio-Fuxai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 1997;7:301-307. Griendling K.K., Alexander R.W. Oxidative stress and cardiovascular discase. Circulation. 1997; 96: 3264-3265. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994; 74: 1141-1148. Griendling К.К., Ollerenchaw J.D., Minieri С.А., AlexanderR.W. Angiotensin 2 stimulates NADH and NADPH activity in cultured vascular smooth musele cells. Clin Res 1994;74:1141-1148. Grines C.L. The role of statins in reversing atherosclerosis: what the latest regression studies show. : J Interv Cardiol. 2006 Feb; 19(1):3–9. Grisham M.В., Jourd’Heuil D., Wink D.A. //Am. J. Physiol. Gastrointest. Liver Physiol. –1999. – 276, N 2. – P. G315-G321. Grotta J.C (1999) Acute stroke therapy at the millennium: consummating the marriage between the laboratory and bedside. The Feinberg Eecture. Stroke, 30(8): 1722-1728. Grunfeld S., Hamilton C., Mesaros S. et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995;26:854-857. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction // Lancet 1994; 343:1115-1122. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial // J Am Coll Cardiol 1996; 27:337-344. Guetta V., Quyyumi A.A., Prasad A. et al. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997; 96:2795–801. Guiliano D., Marfella R., Verazzo G. еt al. The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest 1997; 99:433-438. Guillot F., Misslin P., Lemaire M. Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods. J Cardiovasc. Pharmacol., 1993; 21:339-346. Guittet O., Ducastel В., Salem J.S. et al. // Ibid. – 1998. – 273, N 34. – P. 22136-22144. Gustafsson L.E., Leone A.M., Perssn M.G. Endogenous Nitric Oxide is present in the exhaled air of rabbits, guinea and pigs humans // Biochem. Biophys. Res. Com. – 1991. –Vol. 181. – P. 852-857. Habib A., Creminon C., Frobert Y., Grassi J., Pradelles P. & Maclouf J. (1993) J. Biol. Chem. 268, 23448-23454. Hachinski V.C., Lassen N.A., Marshall Y. Multi-infarct dementia: a cause of mental deterioration in the elderly // Lancet. 1974. V. 2. P. 207. Hacket D., Davies G., Maseri A. Pre-existing coronary stenosis in patients with first myocardial infarction are not necessary severe. Europ. Heart J. 1988, 9: 1317-1323. Haffner S.M. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Diabetes Care. 1997 Apr;20(4):469-71. Hahn A.W., Resink T.J., Scott-Burden T. et al. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regulation. 1990; 1: 649-659. Halcox J.P., Deanfield J.E. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation. 2004 Jun 1;109(21 Suppl 1):II42-8. Haley E.C., Kassell N.F., Torner J.C., Truskowski L.L., Germanson TP. 1994. J Neurolog 80:788-796. Haley E.C., Kassell N.F., Torner J.C. (1993). J neurosurg 78: 537-553. Hall R., Chong C. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina // Cardiology 2001; 96:72-77. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57: 715S-725S. Halliwell B. // FEBS Lett. – 1997. – 411, N 2-3. – P. 157-160. Hambrecht R., Hilbrich L., Erbs S. et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000;35:706-713. Hamson D.G. Endothelial function and oxidant stress. Clin. Cardiol. 1997; 20 (SII): II-11-II-17. Hanninen T., Hallikainen M., Tuomainen S. et al. Prevalence of mild cognitive impairment: a population-based study in elderly subjects // Acta Neurol. Scand. 2002. Vol. 106. P. 148-154. Hansson L., Lithell H., Scoog I. et al. Study on cognition and prognosis in the elderly (SCOPE) // Blood Pressure. 1999. V. 8. P. 177–183. Hanyu H., Tanaka Y., Asano T. et al. Parkinsonism in patients with subcortical arteriosclerotic encephalopathy: A magnetic resonance imaging study // Geriatr. Gerontol. Internat. 2002. Vol. 2. P. 30-35. Harmon B.V., Corder A.M., Collins R.J., Gobe G.C., Allen J., Allan D.J., Kerr J.F. (1990) Intern. Radiat. Biol. 58, 845-858. Harnson D.G., Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: Implications for impaired vasomotion. Amer. J. Cardiol. 1995, 75: 75B-81B. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 2:2153-2157. Hassan H.H., Denis M., Krimbou L. Cellular cholesterol homeostasis in vascular endothelial cells. Can J Cardiol. 2006 Feb; 22 Suppl B:35B–40B. Hayashi K., Kurokawa J., Nomura S. Effect of fluvastatin sodium (XU 62320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzymeA reductase, on the induction of low-density lipoprotein receptor in HepG2 cells. Bioch. Biophys. Acta, 1993; 30:305-306. Hayward L.J., Rodriguez J.A., Kim J.W. Et al. // J. Biol. Chem. – 2002. – 277, N 18. – P. 15923-15931. Hazell A.S. N-acetylcysteine attenuates early induction of heme oxygenase-1 following traumatic braininjury // Brain Res. – 2005. – Vol. 1033. – P. 13-19. Hebert R., Brayne C. Epidemiology of vascular dementia // Neuroepidemiol. 1995. Vol. 14. P. 240-257. Hedin S.G. Uber die bildung von arginin aus proteinkorper. Z Physiol Chem 1895; 21:155168. Heitzer T., Just H., Munzel T. Antioxidant vitamin С improves endothelial dysfunction in chronic smokers. Circulation, 1996: 94: 6-9. Heitzer Т., Via Herttuala S., Luoma J. et al. Cigarette smoking potentiates endothelial dislunction of forearm resistance vessels in patients with hypercholes-terolemia. Role of oxidized LDL. Circulation. 1996, 93: 1346-1353. Hennig L., Andresen D., Hennig A., et al. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia // J Clin Pharmacol 1991;31:636-640. Herbert J., Goodyer I.M., Grossman A.B., Hastings M.H., de Cloet E.R., Lightman S.L., Lupien S.J., Roozendaal B., Seck J.R. Do corticosteroids damage the brain? // Journal of Neuroendocrinology. – 2006, Vol. 18, P. 393-411. Herrington D. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection. Can J Cardiol 2000; Aug; 16 Suppl E:5E–9E. Herrsshaft H., Kunze U., Glein F. Die Wirkung von Actovegin anf die Gehinstaffwech sel des menschen // Med Welt. 1977. Bd. 28. S.339-345. Hershey L.A., Olszewski W.A. Ischemic vascular dementia // In: Handbook of Demented Illnesses. Ed. By J.C. Morris. New York etc.: Marcel Dekker, Inc. 1994. P. 335–351. Higashi Y., Oshima Т., Orono R. et al. Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients. Am J Hypertens 1999;12:8-15. Hill M., Takano H., Tang X.L. et al. Nitroglycerin induces late preconditioning against myo-cardial infarction in conscious rabbits despite development of nitrate tolerance // Circulation 2001;104(6):694-699. Hippisley-Cox J., Cater R., Pringle M. Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices. BMJ, Mar 2003; 326: 689. Hobbs A.I., Fukuto I.M., Iguarro L.I. // Ibid. 1994. 91. P. 10992-10996. Hof R.J., Hocking L., Wright P.K., Ralston S.H. Nitric oxide is a mediator of apoptosis in the rheumatoid joint// Rheumatology. – 2000. – Vol. 39, № 9. – P. 1004-1008. Hogg N., Sing R.J., Konorev E. et al. I.I. Biochem. J. – 1997. – 323, N 2. – P. 477-481. Hogg N., Kalyanamman B., Joseph J. Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis. FEBS Lett, 1993; 334: 170-174. Holm Р., Andersen L., Andersen М., Erhardtsen Е., Stender S. The Direct Antiatherogenic Effect of Estrogen Is Present, Absent, or Reversed, Depending on the State of the Arterial Endothelium A Time Course Study in Cholesterol-Clamped Rabbits Circulation. 1999; 100:1727-1733. Homing B., Maier V., Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation, 1996; 93: 210-214. Houston M., Chumley P., Radi R. et al. // Arch. Biochem. Biophys. – 1998. – 355, N1. – P. 1-8. Huang K.P., Huang F.L. // Biochem. Pharmacol. – 2002. – 64, N 5-6. – P. 1049-1056. Hulette C.M. Brain banking in the United States // J Neuropathol Exp Neurol. 2003. Vol. 62. N. 7. P. 715-722. Hulley S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary artery disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280:605-13. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America // Circulation 2001; 104(24):2996-3007. Ibi M. Sawada, H. Nakanishi, M. Kume, T. Katsuki, H. Kaneko, S. Shimohama and Akaike, A. (2001) Neuropharmacol., 40, 761-771. Ignarro L.J., Cirino G., Casino A. et al. Nitric oxide as a signating molecule in the vascular system: an overview. J Cardiolvasc Pharmacol 1999; 34:879-886. Ignarro L.J., Napoli C., Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. Аn overview. Circulat Res 2002; 90:l:21-28. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Endothelium derived relaxing factor from pulmonary artery and vein possesses pharmaciilogical and chemical properties identical to those of nitric oxide radical. Circul. Research. 1987; 61: 866-879. Ikeda U. Prevention and early intervention for vascular dementia in community dwelling elderly: Findings from the Nakayama study // Psychogeriatrics. 2003. Vol. 3. P. 17-20. Ikeda U., Ito T., Shimada K. Statins and C-reactive protein. Lancet 1999; 353:1274-1275. Induction of nitric oxide synthase by traumatic braininjury // Y. Orihara, K. Ikematsu, R. Tsuda, I. Nakasono // Forensic. Sci. Int. – 2001. – Vol. 123. – P. 142-149. Insull W., Black D., Dujovne С. et al. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia. Arch. Intern. Med., 1994; 154:2449-2455. Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewski(eds) H.M. Alzheimer's Disease: Biology, Diagnosis and Therapeutics John Willey and Sons Ltd. 1997. 830 p. Irani K. Oxidant signaling in vascular cell growth, death and survival. Circulat Res 2000;87:179-190. Ischiropoulos H., Zhu L., Chen J. et al. // Arch. Biochem Biophys. – 1992. – 298, N 3. –P. 431-437. Ischiropoulos H. // Arch. Biochem. Biophys. – 1998. – 356, N 1. – P. 1-11. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction // Lancet 1995; 345:669-685. Itoh Т., Matsuya Y., Maeta H. et al.. // Chem. Pharm. Bull. – 1999. – 47, N 1. – P. 133-135. Jaffe R., Ariel I.; Beeri R., Paltiel O., Hiss Y., Rosen S., Brezis M. 1997 Exp. Nephrol. 5, 399-403. Jancovic J. Theories on the ethiology and pathogenesis of Parkinson's disease // Neurology. 1992. V. 42. P. 21-23. Jaranowska A. et al. Molec. Chem Neuropath. – N2.-P.95-106.-1995. Jay M.T., Chirieo S., Siow R.C. et al. Modulation of vascular tone by low-density lipoproteins: effect on L-arginine transport and nitric oxide synthesis. Exp Physiol 1997; 82:349-360. Jean-Baptiste Michel Nitric oxide and Cardiovascular Homeostasis 1999 Menarini International Industrie Farmaceutiche Riunite s.r.l. Paris. Jelic V., Winblad B. Treatment of mild cognitive impairment: rationale, present and future strategies // Acta Neurol. Scand. 2003. Vol. 107 (Suppl. 179). P. 83-93. Jellinger K.A. Pathology of parkinsonism / Recent Developments in Parkinson's Disease. New York: Raven Press, 1986. P. 33-36. Jensen-Urstad K.J., Reichard P.G., Rosfors J.S. et al. Early atherosclerosis is retarded by improved long-term blood-glucose control in patients with IDDM. Diabetes, 1996; 45: 1253-1258. Jeremy R., McCarron N., Sulivan D. Effect of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit: response according to treatment duration, anatomic site and sex. Circulation 1996; 94:488-506. Jesberger J.A., Richardson J.S. (1991) Oxygen free radicals and brain dysfunction. Int. J. Neurosci., 57(1–2): 1-17. Jia Z., Bonaventura C., Bonaventura J., Stamler J.S. // Nature. – 1996. – 380, N 6571. – P. 221-226. Jia Z. and Nimere, I. (1999) Steroids, 64, 541-550. Joannides R., Haefeli W.E., Linder L. et al. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation, 1995: 91: 1314-1319. Jocubaitis L. Updated clinical experience with fluvastatin. Am J Cardiol 1994; 73:18-24. Johnson A., Mackway-Jones K. Frusemide or nitrates in acute left ventricular failure // Emerg Med J 2001; 18:59-60. Johnstone M.T. Creager S.L., Scales K.M. et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation, 1993; 88: 2510-2516. Jorm A.F., Korten A.E., Henredson A.S. The prevalence of dementia: A quantitative integration of the literature // Acta Psychiatr. Scand. 1987. Vol. 76. P. 465-479. Jourd’heueil D., Hallen K., Feelisch M., Grisham M.В. Dynamik state of S-nitrosothiols in human plasma and whole blood. Free Radic Biol Med – 2000. – 28, N 3. – P. 409-417. Jourd’heuil D., Kang D., Grisham M.B. // Frontiers in Bioscience. – 1997. – 2. – P. dl89-dl96. Jugdutt B.I., Khan M.I., Jugdutt S.J. et al. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate // Circulation 1995; 92:926-934. Jugdutt B.I., Warnica J.W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complication: effect of timing, dosage and infarct location // Circulation 1988; 78:906-919. Junquero D.C., Schini V.B., Vanhoutte P.M. Indapamide potentiates the endothelium-dependent production of cyclic guanosine monophosphate by bradykinin in the canine femoral artery. Am Heart J 1991 Oct; 122 (4 Pt 2):1204-9. Kaasjager K.A., Koomans H.A., Rabelink T.J. (1997) Endothelin-1 induced vasopressor responses in essential hypertension. Hypertension, 30(1 Pt 1): 15-21. Kagami S., Border W.A., Miller D.A., Nohle N.A. Angiotensin II stimulates extracellular matrix protein syntliesis through induction ot transforming growth factor В in rat glomerular mesangial cells. J. Clin. Invest, 1994: 93:2431-2437. Kagiyama S., Tsuchihashi Т., Abe I., Fujishima M. Cardiovascular effects of nitric oxide in the rostral ventrolateral medulla of rats// Brain Res. – 1997. – 757. – P.155-158. Kalueff A.V., K.O. Eremin, Tuohimaa P., Kamal E., Habib M.D., Philip W., Gold M.D., George P. Chrousos. Neuroendocrinology of stress //Endocrinology and Metabolism Clinics. – Vol. 30 – №3, 2001. – Р. 695-728. Kamei Y., Kawada T., Fukuwatori T., Ono T., Kato S. and Sugimoto, E. (1995) Gene, 152, 281-282. Kanowsky S., Kinzler E., Lehman E. et al. Confirmed clinical efficacy of actovegin in elderly patients with organic brain syndrome // Pharmacopsychiat. 1995. V. 28. P. 125-133. Kaplan K.D.R., Parker M., Przybylek J. et al. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy // Am J Cardiol 1983; 51:694-698. Kaplan N.M. The ASCOT trial: a closer look. J Hypertens. 2006 Feb; 24(2):211–4. Kari J.A., Donald A.T., Vallance D.T. et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Intern 1997; 52:468-472. Kaski J.C., Plaza L.R., Meran D.O., et al. Improved coronary supply: prevailing mechanism of action of nitrates in chronic stable angina // Am Heart J 1985; 110:238-245. Kataoka H., Otsuka F., Ogura T., Yamauchi T., Kishida M., Takahashi M., Mimura Y., Makino The role of nitric oxide and the rennin-angiotensin system in salt-restricted Dahl rats. H Am J Hypertens 2001 Mar; 14(3):276-85. Katayama Y. // Dojindo Newsletter. – 1995. –N 1. – P. 1-36. Katsuki H. & Okuda S. 1995 Prog. Neurobiol. 46, 607-636. Katz R.J., Levy W.S., Buff L. et al. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors // Circulation 1991; 83:1271-1277. Katzenschlager R., Lees A.J. Treatment of Parkinson's disease: levodopa as the first choice // J Neurol. 2002. V. 249 [Suppl 2]. P. II/19-II/24. Kaushik P.Patel, Yi-Fan Li, Yoshkitaka Hirooka. Role of Nitric Oxide in Central Sympathetic Outflow // Experimental Biology and Medicine. 2001; 26, Р. 814-824. Kavanagh B.P., Pearl R.G. // Int. Anestesiol. Clin. – 1995. – Vol. 33. – P. 181-210. Kavanaugh W.M., Williams L.T. Science, 1994, 266. – P.1862-1865. Kazuhiro S., Michel T. (1997) Expression and regulation of endothelial nitric oxide synthase. TCM, 7(1): 28-37. Ke J.P., Low N.O. and atherogenesis. PNAS 2003; 100:3:768-770. Kearney D., Fitzgerald D. The anti-thrombotic effects of statins. J Am Coll Cardiol 1999; 33:1305-7. Keese M.A., Bose M., Mulsch A. et al. //Biochem. Pharmacol. – 1997. – 54, N 12. – P. 1307-1313. Keller J.N., Schmitt F.A., Scheff S.W. et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment // Neurology. 2005. Vol. 64. P. 1152–1156. Kharitonov S.A., Alving K., Barnes P.J. Exhaled and nasal nitric oxide measurements: recommendations // Eur. Resp. J. –1997. – Vol. 10. – P. 1683-1693. Kidd G.A., Dobrick L.W., Brovkovych V. et al. Nitric oxide deficiency contributes to large cerebral infarct size. Hypertension 2000;35:1111-1118. Kiechle F.L., Malinski T. // Amer. J. Clin. Pathol. – 1993. – Vol. 100. – P. 567-575. Kielstein J.T., Bode-Boger S.M., Haller H. et al. Functional changes in ageing kidney: is there a role for asymmetric dimethylarginine? Nephrol Dial Transplant 2003; 18:7:1245-1248. Kim Y.M., Bergenia H.A., Muller С, Р.I.В. R. et al. // J. Biol. Chem. – 1995. – 270, N 11. – P. 5710-5713. Kimura M., Kurose I., Russell J. et al. Effects of fluvastatin on leukocyte- endothelial cell adhesion in hypercholesterolemic rats. Arterioscler Thromb Vasc Biol 1997; 17:1521-6. Kingwell B.A. Nitric oxide–mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 2000 Sep; 14(12):1685-96. Kishi Y., Watanabe T., Makita T., Sakita S., Watanabe R., Ashikaga T., Numano F. Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells. J Cardiovasc Pharmacol. 1995; 26:590-595. Kiеlstein J., Bode-Boger Т., Frolich J.С. et al. Asymmetric dimethylarginine, blood pressure and renal perfusion in elderly subjects. Circulation 2003;107, V. 14:1891-1895. Klahr S., Morrissey J. Angiotensin II and gene expression in the kidney // Am. J. Kidney Dis. – 1998. – Vol. 31. - №1. – Р. 171-176. Klang O., Rolstad S., Nordlung A. Mild Cognitive Impairment of primary and vascular aetiology: differences in episodic memory? // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 48-49. Klatt P., Schmidt K., Uray G., Mayer B. 11 J. Biol. Chem. 1993. 268. P. 14781-14784. Kleemann R., Kooistra T. HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec; 5(6):441-453. Kleinert H., Wallerath Т., Euchenhofer С. et al. Ulrich Forstermann Estrogens Increase Transcription of the Human Endothelial NO Synthase Gene Analysis of the Transcription Factors Involved Hypertension. 1998; 31:582-588. Kleschov A.L., Hubert G., Munzel T. et al. // BMC Pharmacology. – 2002 http://www. Biomedcentral. Com/1471-2210/2/3. Kleschyov A.L., Muller В., Keravis T. et al. // Am. J. Physiol. Heart Circ. Physiol. – 2000. –279, N 6. – P. H2743-H2751. Kloner R.A., Shook T., Przyklenk K., et al. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? // Circulation 1995; 91:37-47. Kluge I., Gutteck-Amsler U., Zollinger M., Do KQ. S-nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J Neurochem 1997; 69: 2599-607. Knowles R.G., Moncada S. I I Trends Biochem. Sci. 1993. 17, N 10. P. 399-402. Koizumi J., Haraki T., Kunimaza Y. et al. Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemia. Am J Cardiol 1995; 76:47-50. Kojda Т., Harrison D. Interaction between NO and reactive oxigen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart Failure. Cardiovasc Res 1999; 43:562-571. Kolpakov V., Gordon D., Kulik T.J. Nitric oxide-generating compounds inhibit total protein and collgen synthesis in cultured vascular smooth cells. Circul. Res. 1995; 76: 305-309. Konijn A.M., Glickstein H., Vaisman B. et al. //Blood. – 1999. – 94, N 6. – P. 2128-2134. Koppenol W.H.B. Quim. Nova. – 1998. – 21, N 3. – P. 326-331. Kou V., Nassisi D. Unstable angina and non-ST-segment myocardial infarction: an evidence-based approach to management // Mt Sinai J Med 2006; 73:449-468. Krenek P., Salomone S., Kyselovic J., Wibo M., Morel N., Godfraind T. Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats. Hypertension 2001; 37: 1124-1128. Kroncke K.D., Klotz L.O., Suschek C.V. and Sies, H. (2002) J. Biol. Chem., 277, 13294-13301. Kruszewski M., Iwanenko T. // Acta Biochim. Pol. – 2003. – 50, N 1. – P. 211-215. Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Amer. J. Physiol. 1992; 262: H611-H615. Kubes P., Suzuki M., Granger D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA., 1991; 88:4651-4655. Kuller L.H., Matthews K.A., Sutton-Tyrrel K. et al. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. Artherioscler. Thromb. Vasc. Biol. 1999; 19:2189-2198. Kumor V., M. Calach. Treatment of Alzheimer's disease with cholinergic drugs // Int J Clin Pharm Ther Toxicol. 1991. V. 29. № 1. P. 23-37. Kurioka S., Koshimura K., Sugitani M. et al. Analysis of urinary nitric oxide metabolites in healthy subjects // Endocr.J. – 1999. – Vol. 46, № 3. – P. 421-428. Kwak B.R., Mach F. Statins inhibit leukocyte recruitment-new evidence for their anti-inflammatory properties. Arterioscler Thromb Biol 2001; 21:1256-1258. Lacoste L.L., Theroux P., Lidon R.M. et al. Antithrombotic properties of transdermal nitro-glycerin in stable angina pectoris // Am J Cardiol 1994; 73(15):1058-1062. Lancaster J.R. Jr. // Proc. Natl. Acad. Sci. USA. – 1994. – 91, N 15. – P. 8137-8141. Langham J., Goldfrad C., Teasdale G., Shaw D., Rowan K. (2000). Cochrane Database Syst Rev 2000; (2): CD000565. Langub, M.C., Herman, J.P., Malluche, H.H., and Koszewski, N.J. (2001) Neurosci., 104, 49-56. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM. J Neurosurg 1999 Jun; 90(6):1011-7. LaRosa J.C., Jiang H., Vupputuri S. Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials. JAMA, Dec 1999; 282:2340-2346. Larrabee G.J., Crook T. M. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function // Int Psychogeriatr. 1994. V. 6. N.1. P. 95-104. Larrat E.P. Cost-effectiveness study of nitrate therapy using a decision analysis methodology // Hosp Formul 1994; 29(4):277-278. Lasher T.F. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. Basic Research. Cardiol. 1993; 88(SI): 15-24. Latini R., Staszewsky L., Maggioni A.P. et al. Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial. Am Heart J 2003; 146(1):133-141. Laufs U., Fata V., Plutzky О. et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97:1129-35. Law M., Wald N.J. Efficacy and safety of cholesterol-lowering treatment. Lancet 2006 Feb 11; 367(9509):469-70. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D. & Hwang D.(1992 J. Biol. Chem. 267, 25934-25938. Lees K.R; Asplund K.; Carolei A.; Davis S.M.; Diener H.C.; Kaste M.; Orgogozo J.M.; Whitehead J. Lancet. 2000 Aug 12; 356(9229):597; Lancet. 2000 Jun 3; 355(9219):1925-6. Lefer A.M. Nitric oxide: Nature's naturally occuring leukocyte inhibitor. Circulation, 1997; 95: 553-554. Lefer D.J., Scalia R., Jones S.P. et al. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemiareperfusion injury. FASEB J 2001; 15:1454-1456. Leone A.M., Gusiafsson L.E., Francis L.P. Nitric oxide is present in exhaled breath in humans: Direct GC-MS confirmation // Biochem. Biophys. Res. Com. – 1994. – Vol. 201. – P. 883-887. Leppert D., Waubaunt Ј., Galardy R. et al. T-cell gelatinases mediate basement membrane transmigration in vitro // J. Immunol. – 1995. – Vol. 154. – P. 4379-4389. Lerman A., Burnett J.С., Higano S.T. et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998; 97:2123-2128. Leu H.B., Chen J.W., Wu T.C. et al. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia. Clin Cardiol. 2005 Sep; 28(9):423-8. Levine G.V., Erei B., Koulouris S.N. et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery discase. Circulation 1996; 93: 1107-1113. Levy R. Aging-associated cognitive decline // Int Psychogeriatr. 1994. V. 6. P. 63-68. Lewis B.S., Rabinowitz B., Schlesinger Z., et al. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study // Cardiology 1999; 91(1):1-7. Lezak M.D. Neuropsychology assessment // N.Y. University Press. 1983. P. 768. Li G.L., Farooque M., Holtz A., Olsson Y. (1999) Acta Neuropathol. (Berl) 98, 473-480. Li H. Nitric oxide in the patogenesis of vascular disease / H. Li, U. Forstermann // J. Pathol. 2000. Vol. 190(3). P. 244-254. Li H., Meininger C.J., Hawker J.R. et al. Regulatory role of arginase I and II in nitric oxide, polyamine and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab 2001; 280:E75–E82. Li Y.C., Pirro A.E. and Demay M.B. (1998) Endocrinol., 139, 847-851. Liao J.K. Clinical implications for statin pleiotropy. Curr Opin Lipidol. 2005 Dec; 16(6):624-629. Liao J.К. Endothelium and acute coronary syndromes. Clin Chem 1998; 44:1799-1808. Lin K.Y., Ito A., Asagami T. et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine dimethylaminohydrolase. Circulation 2002; 106:987-992. Lin A.M., Fan S.F., Yang D.M., Hsu L.L. and Yang C.H. (2003) Free Radic. Biol. Med., 34, 1416-1425. Lipton S.A., Rosenberg P.A. 1994. N Engl J Med 330: 613-622. Little W.C., Constantinescu M., Applegate R.G. et al. Can coronary angiography predict the site of subsequent myocardial infarction in patients with mils-to-moderatecoronary disease? Circulation 1988: 78: 1157-1166. Littler W.A., Sheridan D.J. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group // Br Heart J 1995; 73:428-433. Liu X., Miller M. J. S., Joshi M.S. et al. // Proc. Natl. Acad. Sci. USA. – 1998. – 95, N 5. – P. 2175-2179. Liu Z., Rudd M.A., Freedman J.E., Loscalzo J. S-Transnitrosation Reactions Are Involved in the Metabolic Fate and Biological Actions of Nitric Oxide. J pharmacol experiment ther 1998; 284 (2): 526-34. Losel R. and Wehling, M. (2003) J. Steroid Biochem. Mol. Biol., 83, 167-171. Losel R. and Wehling M. (2003) Nature Revs Mol. Cell Biol., 4, 46-55. Lovenstone S., Gauthier S. Management of dementia // London: Martin Dunitz. 2001. Lowenstein C.J., Dinerman J.L., Snyder S.H. // Ann. Intern. Med. – 1994. – Vol. 120, N 3. – P. 227-237. Ludmer P.L., Selwyn A.P., Shook T.L. et al. Paradoxical vasoconstriction induced by acetylcholin in athero-sclerotic coronary arteries. New Engl. J. Med. 1986, 315: 1046-1051. Luscher T.F. (Endothelial dysfunction as a therapeutic target) The ENCORE trials Euuropean Heart J Supplements 2000; 2 (Supplement D), D20-25. Luscher T.F., Barton M. (1997) Biology of the endothelium. Clin. Cardiol., 20 (11 Suppl. 2): 3-10. Lymar S.V., Hurst J.К. // J. Am. Chem. Soc. – 1995. – 117. – P. 8867-8868. Mahmarian J.J., MoyО L.A., Chinoy D.A. et al. Transdermal nitroglycerin patch therapy im-proves left ventricular function and prevents remodeling after acute myocardial infarction: re-sults of a multicenter prospective randomized, double-blind, placebo-controlled trial // Circulation 1998; 97:2017-2024. Mallis R.J, Buss J.E, Thomas J.A. // Oxidative modification of H-ras: S-thiolation and S-nitrosilation of reactive cysteines. Biochem. J. – 2001. – 355, N 1. – P. 145-153. Mancini G.D.J., Henry G.C., Macaya С. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation 1996; 94:258-265. Mannick J.B., Hausladen A., Liu L. et al. Fas-induced caspase denitrosylation. Science 1999; 284: 651-4. Manukhina E.B., Mashina S.Yu., Smirin B.V. et al. Role of nitric oxide in adaptation to hypoxia and adaptive defense // Physiol. Res. – 2000. – Vol. 49. – P. 89-97. Marcheselli V.L. & Bazan N.G. 1996 J. Biol. Chem. 271, 24794-24799. Marchioli R., Investigators G.T. Beneficial effects of statins. The Lancet 1996; 348:1582. Maria F., Pedersen J.Z., Caccuri A.M. et al. // J. Biol. Chem. – 2003. – 278, N 43. – P. 42283-42293. Marin J., Rodriges-Martinex M.A. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 1997; 76:111-134. Mark L.P., Prost R.W., Ulmer J.L. et al. Pictorial review of glutamate excitotoxicity: Fundamental concepts for neuroimaging // Amer. J. Neuroradiol. 2001. Vol. 22. P. 813-1824. Marshall L.F., Maas A.I., Marshall S.B., Bricolo A., Fearnside M., Iannotti F., Klauber M.R., Lagarrigue J., Lobato R., Persson L., Pickard J.D., Piek J., Servadei F., Wellis G.N., Morris G.F., Means E.D., Musch B. J Neurosurg 1998 Oct; 89(4):519-25. Masada T., Hua Y., Xi G., Yang G.Y., Hoff J.T., Keep R.F. J Neurosurg 2001 Oct; 95(4):680-6. Masuda H., Goto M., Tamaoki S., Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitor for NO synthesis in rabbit with alloxan-induced hyperglycaemia. Br J Pharmacol 1999; 226:1:211-218. Masuda H., Tsujii Т., Okano T. et al. Accumulated endogenous inhibitors, decreased NOS activity and impaired covernosal relaxation with ischemia. Am J Physiol Reg Integr Comp Physiol 2002; 282:R1730-R1738. Masuda Y., Goto M., Tamacki S., Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitor for NO synthesis in rabbit with alloxan-induced hyperglycaemia. Br J Pharmacol 1999; 226:211-218. Matsumura K., Tsuchihashi Т., Kagiyama S., Abe I., Fujishima M. Role of nitric oxide in the nucleus of the solitary tract of rats// Brain Res. – 1998. – 798. – P.232-238. Maxwell A.J., Anderson B.L., Cooke J.P. Nutritional therapy for peripheral arterial disease: adoubl-blind, placebo-controlled randomized trial of Near Bar. Vase Med 2000; 5:11-19. Maxwell A.J., Anderson В. L., Zapien M.P. et al. Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enchance nitric oxide activity. Cardiovasc Drugs 2000; 14:309-316. Maxwell A.J., Cooke J.P. Cardiovascular effects of L-arginine. Curr Opin Nephrol Hypertens 1998; 7:63-70. Mayer В., Werner E.R. In search of a function for tetrahydrobioptcrin in the biosynthesis of nitric oxide. Naunyn Schmiedebergs Arch Pharmacol. 1995:351: 453-463. McCaffrey M.J., Rose C.L., Reiter P.D. et al. Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate 1995;67:240-243. McLeod J.F. and Cooke N.E. (1989) J. Biol. Chem., 264, 21760-21769. McMahon T.J, Moon R.E., Luschinger B.P. et al. // Circ. Res. – 2004. – 94, N 4. – P. 414- 417. McNamara D.B., Bedi B., Aurora H. et al. L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 1993; 1993: 291-296. Mechanisms of neuroprotective action of vitamin D3. Meehan T.F., and DeLuca H.F. (2002) Arch. Biochem. Biopsys., 408, 200-204. Meguro K., Ishii H., Yamaguchi S. et al. Is Vascular Cognitive Impairment the preclinical stage of Vascular Dementia: The Tajiri Project // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 71. Meldrum B.S., Evans M.C., Swan J.H., Simon R.P. Med. Biol. 1987. V.65. N.2/3. P.153-157. Melino G., Catani M.V., Corazxari M. et al. // Cell Мої. Life Sci. – 2000. – 57. – P. 612-622. Meredith I.T., Alison J.F., Zhang F.M. et al. Captopril potentiates the effects of nitroglycerin in the coronary vascular bed // J Am Coll Cardiol 1993; 22:581-587. Meredith I.T., Yeung A.C., Weidinger F.F. et al. Role of impaired endotheliuin-dependent vasodilatioii in iscnemic manifestations ot coronary artery disease. Circulation, 1993, 87 (S.V): V56-V66. Merola B., Longobardi S., Colao A. et al. Tumor necrosis factor-alfa increases after corticotrophin-releasing hormone administration in Cushing’s disease. In vivo and in vitro studies. //Neuroendocrinol. 1996. – Vol. 64. – №5. – Р. 393-397. Merrill J., Murphy S. Inflammation events at the blood brain barrier regulation of adhesion molecules, cytokines and chemokines by reactive nitrogen and oxygen species // Brain Behav. Immun. – 1997. – No.11. – P. 245-263. Meyer J.S., Xu G., Thornby J. et al. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer’s disease? // Stroke. 2002. Vol. 33. P. 1981-1985. Miettinen S., Fusco F.R., Yrjanheikki J., Keinanen R., Hirvonen T., Roivainen R., Narhi M., Hokfelt T., Koistinaho J. Proc Natl Acad Sci U S A 1997 Jun 10; 94(12):6500-5. Mikkelsen S., Jorgensen H., Larsen P.S., Brennum J., Dahl J.B. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):452-8. Miles A.M., Bohle D.S., Glassbrenner P.A. et al. // J. Biol. Chem. – 1996. – 271, N 1. – P. 40-47. Millar Т.М., Stevens С.R., Benjamin N. et al. // FEBS Lett. – 1998. – 427, N 2. – P. 225-228. Miller L.S., Morita Y., Rangan U., Kondo S., Clemens M.G., Bulkley G.B.. Int J Microcirc Clin Exp. 1996 May-Jun; 16(3):147-54. Miller M.J.S., Sandoval M.T. // Am. J. Physiol. Gastrointest. Liver Physiol. – 1999. –276, N 4. – P. G795-G799. Miller R.Т., Martasek P., Roman L.J. et al. // Biochemistry. – 1997. – 36, N49. – P. 15277-15284. Minghetti L., Levi G. Prog Neurobiol 1998 Jan; 54(1):99-125 Related Articles, Books, LinkOut. Miranda K. M., Espey M. G., Yamada K. et al. // J. Biol. Chem. – 2001. – 276, N 3. –P. 1720-1727. Miyasaki J.M., Martin W., Suchowersky O. et al. Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review report of the quality standards subcommittee of the American Academy of Neurology // Neurology. 2002. V. 58. P. 11-17. Mohazzab K.M., Kaminski P.M., Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary endothelium. Am J Physiol 1994; 266:H2568-H2572. Mollinau H., Wendt M., Szocs K. et al. Effect of angiotensin 2 infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circulat Res 2002; 90:58-65. Mombouli J.V. ACE inhibition, endothelial function and coronary artery lesions: role ofkinins and nitric oxide. Drugs 1997; 54:Suppl 5:12-22. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9:1319-1330. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology // Pharmacol. Rev. – 1991. – Vol. 43, № 1. – P. 109-142. Mora S., Ridker P.M. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) – can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol. 2006 Jan 16; 97(2A):33A–41A. Morgan M.K., Jonker B., Finfer S., Harrington T., Dorsch NW.2000. J Clin Neurosci 2000 Jul; 7(4):305-8. Morrison R.A., Weigand U.W., Jahnchem E. et al. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual and percutaneous dosing in angina // Clin Pharmacol Ther 1983;33:747-756. Moss A.J., Goldstein R.E., Hall W.J. et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event // JAMA 1993;269:2379-2385. Muiesan M.L., Salvetti М., Monteduro С. et al. Effect of Treatment on Flow-Dependent Vasodilation of the Brachial Artery in Essential Hypertension Hypertension. 1999; 33:575-580. Muir K.W., Grosset D.G. (1999) Neuroprotection for acute stroke: making clinical trials work. Stroke, 30(1): 180-182. Mukae N., Enari M., Sakahira H., Fukuda Y., Inazawa J., Toh H., Nagata S. 1998 Proc. Natl. Acad. Sci. U S A 95, 9123-9128. Muller С.M., Scierka A., Stiller R.L. еt al. //Anesthesiology. – 1996. – 84, N 6. – P. 1435-1442. Mulsch A., Mordvintcev P.I., Vanin A.F., Busse R // FEBS Lett. – 1991. – 294, N 3. – P. 252-256. Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers, and в-adrenergic antagonists // Gilman A.G., Rall T.W., Nies A.S., Taylor P., eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990:764-783. Murphy M.E., Sies H. // Proc. Natl. Acad. Sci. USA. – 1991. – 88, N 23. – P. 10860-10864. Murphy S., Grzybicki D. (1996) Glial NO: normal and pathological roles. Neuroscientist, 2: 90-99. Murrell W. Nitroglycerine as a remedy for angina pectoris // Lancet 1879; 1:80–81:113. Najbar-Kaszkiel A.T., Li С.G. // Clin. Exp. Pharm. Physiol. – 2003. – ЗО, N 5. – P. 1440-1681. Nakagomi T., Sasaki T., Kirino T., Tamura A., Noguchi M., Saito I. & Takakura K. 1989 Stroke (Dallas) 20, 925-929. Nakajima M., Hutchinson H., Morishita R., Hayashida W., Zhang L., Horiuchi M., Pratt R.E., Dzau V.J. The angiotensin type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain of function study using in vivo gene transfer. Proc.Natl.Acad.Sci.U.S.A.1995; 92: 10663-10667. Nakamura Y., Kawai C., Moss A.J. et al. Comparison between Japan and North America in the posthospital course after recovery from an acute coronary event // Int J Cardiol 1996;55:245-254. Nakamura Y., Moss A.J., Brown M.W. et al. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group // Am Heart J 1999; 138(3 Pt 1):577-585. Nakayama N., Ikezono K., Ohura M., Yabuuchi Y. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro. Arzneimittelforschung. 1993; 43:1266-1270. Nakayаma Т., Soma Y., Takahashi Y. et al. Association analysis of CA repeat polymorphism on the endothelial nitric synthase gene to essential hypertension in Japanese. Clin Genet 1997; 51:26-30. Napoli C., Ignarro L.J. Nitric oxide and atherosclerosis. 2001; 5:88-97. Nedospasov A., Rafikov R., Beda N., Nudler E. // Ibid. USA. – 2000. – 97, N 25. – P. 13543- 13548. Nelson G.I.C., Silke B., Ahuja R.C. et al. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart failure following myocardial infarction // Lancet 1983; 1:730-732. Nelson R.G., Kriegsfeld L.J., Dawson V.L., Dawson T.M. Effects of Nitric Oxide on Neuroendocrine Function and Behavior //Frontiers in Neuroendocrinology. 1997; 18, Р. 463-491. Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., De Luca, H.F. and Brachet, P. (1994) Brain Res. Mol. Brain Res., 24, 70-76. Neveu I., Naveilhan P., Menaa C., Wion D., Brachet P. and Garabedian M. (1994) J. Neurosci. Res., 38, 214-220. Ng D.S. The role of statins in oxidative stress and cardiovascular disease. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Apr; 5(2):165-75. Nicetic V., Stojanovich S., Spasic B. // Iugoslav. Physiol. Pharmacol. Acta. – 1998. – 34, N 2. –P. 463-477. Nicholson S., Bonecini-Almeida M.G. еt al. // J. Exp. Med. – 1996. – Vol. 183. – P. 2293-2302. Niebauer J., Maxwell A.J., Lin P.S. NOS inhibition accelerates atherogenesis: reversal by exercise. Am J Phisiol Heart Circulat Physiol 2003; 285:2:H535-H540. Nigris F., Lerman L.O., Ignarro S.W. et al. Beneficial effect of antioxidants and L-arginine on oxidant-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. PNAS 2003;100:1420-1425. Nitric oxide http: // www.whatislife.com/reader2/Metabolism/pathway/Nohtml. Niwa S., Totsuka T., Hayashi S. Inhibitory effects of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line. Int J Immunopharmacol 1996; 18; 669-675. Nordlung A., Rolstad S., Klang O. et al. Mild Cognitive Impairment of primary and vascular aetiology: AD and VaD in their preliminary stages? // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 33. Norman A.W., Ishizuka S. and Okamura W.H. (2001) J. Steroid Biochem. Mol. Biol., 76, 49-59. Novosel D., Lang M.G., Noll G., Luscher T.F. Endothelial dysfunction in aorta of spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination. J. Cardiovasc Pharmacol 1994; 24:979-85. Nutchison S.J., Sudhir K., Sievers R.E. et al. Effects of L-arginine on atherogenesis and endothelial dysfunction due to second hand smoke. Hypertension 1999; 34:44-50. Nyberg G. Current Status of Isosorbide-5-Mononitrate Therapy in Chronic Stable Angina Pectoris // Am J Ther 1994; 1(1):93-101. O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D. & Coleman P. D. 1996 J. Neurochem. 66, 2532-2540. Ochoa J.B., Udekwu A.O., BilliarT.R. et al. (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg., 214(5): 621-626. Oemar B.S., Tschudi M.R., Godoy N. et al. (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation, 97(25): 2494-2498. Oertel W.H., Dodel R. Current therapeutic strategies of Parkinson's disease // Parkinson's disease. Symptomatic versus prevential therapy. 1994. P. 10-35. Ohara Y, Peterson Т.Е., Sayegh H.S. et al. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial super oxide anion production. Circulation 1995; 92:898-903. Ohara Y, Peterson ТЕ, Harnson DG. Hypercholesterolemia increases eiidothelial superoxide anion production. J. Clin. Invest. 1993, 91: 2546-2551. Ohkawa H, Ohishi N, Yagi Kunio, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8. Okura Y., Takao M., Zhang B. et al. Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res. 2004 Oct; 27(10):723-9. Olanow C.W. The scientific basis for the current treatment of Parkinson's disease // Annu. Rev. Med. 2004. V.55. P. 41-60. Olanow C.W., Koller W.C. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines // Neurology. 1998. V. 50 [Suppl 3]. P. 5-46. Olney J.W., McGeer P. Neurotoxicity of excitatory aminoacids. New York, 1978. Ono Y., Ono H., Frohlich E.D. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats. J Hypertens 1996 Jul; 14(7):823-8. Oswald W.D., Steyer W., Oswald B., Kuntz G. Die verbesserung fluider kognitiver leistungen als imdikator fur die klinishe wirksamkeit einer nootropen substanz. Eine placebokontrollierte doppelblind studie mit Actovegin // Z. Gerontopsychol Psychiatric. 1991. Bd4. S. 209-220. Oswald W.D., Steyer W., Oswald B., Kuntz G. Die verbesserung fluider kognitiver leistungen mit Actovegin-infusionen bei alterspatienten mit leichem bis millel schweren organisdom psychosyndrom // Z. Geronto-psychiatrie. 1992. Bd5. S. 251-266. Ozcelikay A.T., Tay A., Guner S. et al. Reversal effects of L-arginine treatment on blood pressure and vascular responsiveness of streptozotocin-diabetic rats. Pharmacol Res 2000; 41:201-209. Packer M., Bristow M.R., Cohn J.N. et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group // N Engl J Med 1996; 334:1349-1355. Palluy O., Morliere L., Gris J.C. et al. (1992) Hypoxia/reoxygenation stimulates endothelium to promote neutrophil adhesion. FreeRadic. Biol. Med., 13(1): 21-30. Palmer G.C. Curr Drug Targets 2001 Sep; 2(3):241-71. Palmer K., Fratiglioni L., Winblad B. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment // Acta Neurol. Scand. 2003. Vol. 107 (Suppl. 179). P. 14-20. Palmer R.M.J., Ferringe A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526. Pantoni L., Garsia J. Pathogenesis of leukoaraiosis // Stroke. 1997. V. 28. P. 652-659. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New Engl. J. Med. 1990; 323: 22-27. Paolocci N., Katori Т., Champion H.С. et al. // Proc. Natl. Acad. Sci. USA. – 2003. – 100, N 9. – P. 5537-5542. Parker J.D., Parker J.O. Nitrate Therapy for Stable Angina Pectoris // N Engl J Med 1998; 338:520-531. Parsons C.G., Danysz W., Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data // Neuropharmacol. 1999. Vol. 38. P. 735-767. Pasceri V., Chang J., Willerson J.T. et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by antiatherosclerotic drugs. Circulation 2001; 103:2531-2534. Patei J.M. ,Abeles A.J., Block E.R. Nitric oxide induced modulation of arginine uptake and nitric oxide synthase activity in pulmonary artery endothelial cells. Am J Resp Crit Care Med 1994; 149:552A. Patti G., Melfi R., Di Sciascio G. The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences. Recenti Prog Med. 2005 Oct; 96(10):499-507. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21:1104-17. Petersen R.C., Stevens J.C., Ganguli M. et al. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology // Neurology. 2001. Vol. 56. P. 1133–1142. Petersen R.S. Current concepts in mild cognitive impairment // Arch. Neurol. 2001. Vol. 58. P. 1985-1992. Petersen R.C., Smith G.E., Waring S.C. et al. Mild cognitive impairment: clinical characterization and outcome // Arch. Neurol. 1999. Vol. 56. P. 303-308. Petersen R.S., Smith G.E., Waring S.C. et al. Aging, memory and mild cognitive impairment // Int. Psychogeriatr. 1997. Vol. 9. P. 37-43. Petrat F., de Groot H., Sustmann R., Rauenl U. // Biol. Chem. – 2002. – 383, N 3-4. – P. 489-502. Petruk K.C., West M., Mohr G. et al. 1988. J Neurosurg 68:505-17. pharmvestnik.ru. (мелатонин). Philippon J., Grob R., Dagreou F., Guggiari M., Rivierez M., Viars P. 1986. Acta Neurochir Wien 82: 110-14. Piatti P., Fragasso G., Monti L.J. et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial fuction in patients with angina pectoris and normal coronary arteriograms. Correlation with ADMA. Circulation 2003; 107:3:429-439. Pickard J.D., Murray G.D., Illingworth R. et al. 1989. Br Med J 298:636-42. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes. Hypertension 1998; 31:1047-1060. Pitt B., Pepine C., o’Neill B., Haber H., Pressler M., Mancini GBJ. Modulation of ACE inhibitor efficacy on coronary endothelial dysfunction by low density lipoprotein cholesterol. J Am Coll Cardiol. 1997; 29 (2, suppl A):70A. Abstract 714-715. Plotnikoff N.P., Faith R.E., Murgo A.G., Good R.A. Cytokines: Stress and Immunity, Second Edition. СRC. 2006, 405 р. Polzar B., Zanotti S., Stephan H., Rauch F., Peitsch M.C., Irmler M., Tschopp J., Mannherz H.G. 1994 Eur. J. Cell Biol. 64, 200-210. Poungvarin N., Bhoopat W., Viriyavejakul A. et al. 1987. N Engl J Med 316: 1229-1233. Prabhakar S.S., Zeballos G.A., Montoya-Zavala M., Leonard С. Urea inhibits inducible nitric oxide synthase in macrophage cell line // Amer. J. Physiol. – 1997. – Vol. 27, № 6. – P. 1882-1888. Prencipe M., Santini M., Casini A.R. et al. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population // J. Neurol. 2003. Vol. 250. P. 907–912. Pritchard K.A., Grosze K.L., Smalley D.M. et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circulat Res 1995; 77:510-518. Prüfer K., Veenstra T.D., Jirikowski G.F. and Kumar R. (1999) J. Chem. Neuroanat., 16, 135–145. Pshennikova M.G., Kuznetsova B.A., Shimkovich M.V., Meerson F.Z. Adaptation Biology and Medicine (B.K.Sharma, N.Takeda, P.K.Ganguly, P.K.Singal eds.). – Narosa Publ. House, New Delhi. – 1997. – Vol. 1. – P. 315-325. Qu X.B., Xiao X., Liu Q., Liu Y.S. Prognostic effect of angina before acute myocardial infarction in elderly patients // Hunan Yi Ke Da Xue Xue Bao 2000; 25(1):80-82. Quinn N. Drug Treatment of Parkinson's disease // BMJ. 1995. V. 310. P. 575-579. Quyyrumi A., Dakak N., Duodati G. еt al. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilatation. J Am Coll Cardiol 1997;30:1220-1227. Radi R. // PNAS. – 2004. – 101, N 12. – Р. 4003-4008. Rafikova O., Rafikov R., Nudler E. // PNAS. –2002. – 99, N 9. – P. 5913-5918. Rajagopalan S., Harrison D.G. Reversing endothelial dysfunction with ACE-inhibitors. A new TREND? Circulation, 1996, 94: 240-243. Rakhita R.D., Marberb M.S. Nitric oxide: an emerging role in cardioprotection? // Heart 2001; 86:368-372. Raley-Susman K.M., Lipton P. Brain Res. 1990. V.515. N.1/2. P.27-388. Ramachandran N., Root P., Jiang X.M., Hogg P.L, Mutus В.И Proc. Nat. Acad. Sci. USA. – 2001. – 98, N 17. – P. 9539-9544. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389. Rapoport R.M., Draznin M.B., Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMO-depcndent protein phosphorviation Nature, 1983:306:174-176. Rauhala P., Lin AM-Y, Chiueh C.C. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 1998; 12: 165-173. Ravindran J., Shuaib A., Ijaz S. et al. Neurosci Lett, 1994, 176. – P.209-211. Rector T.S., Bane A.J., Mullen K.A. et al. Randomized, double-blind placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:2135-2141. Redel J.В., Moore А.К, Dash Р.К. Expression of the prodynorphin gene after experimental brain injury and its role in behavioral dysfunction // Exp. Biol. Med. – 2003. – Vol.228. – P. 261-269. Ricci S., Celani M.G., Cantisani T.A., Righetti E. J Neurol 2000 Apr; 247(4):263-266. Richard V., Joannides R., Henry J.P., Mulder P., Mace B., Guez D., Schiavi P., Thuillez C. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects. J Hypertens 1996 Dec; 14(12):1447-1454. Ridker P.M., Gaboury C.L., Conlin P.R. et al. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation. 1993; 87: 1969-1973. Rikitake Y., Kawashima S., Takeshita S. et al. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterolfed rabbits. Atherosclerosis 2001; 154:87-96. Rilwan A., Ross A., Cooper A. et al. Oral and transdermal oestrogens reduse impedance to blood flow equally in the cerebral circulation of postmenopausal women. IV European Congress on Menopause, Vienna, Austria, 1997, 12. Rink A., Fung K.M., Trojanowski J.Q., Lee V.M., Neugebauer E., McIntosh T.K.1995 Am. J. Pathol. 147, 1575-1583. Rinne U.K., Molsa P. Levodopa with Benserazide or Carbidopa in Parkinson's Disease // Neurology. 1979. V. 29. P. 1584-1589. Ritchie K., Touchon J. Mild cognitive impairment: conceptual basis and current nosological status // The Lancet. 2000. Vol. 355. N. 9199. P. 225–228. Ritter J. (2001) Pharmacological modulation of endothelial function. In: Abstracts of the 11th European Meeting on Hypertension, June 2001, Milan, Italy, pp. 3-5. Robberecht W. // http://www.harcourt-international.com/e-books/pdf/273.pdf. Robert M., Carey; Zhi-Qin Wang; Helmy M. Siragy Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal Function Hypertension. 2000; 35:15. Roberts C.K, Vaziri N.D, Wang X.Q, Barnard R.J Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension 2000 Sep; 36(3) 423-934. Roberts I. Cochrane Database Syst Rev 2000; (4):CD001527. Roberts J.M., Balk L.M., Boodnar L.M. Nutrient involvement in preeclampsia. J Nutr 2003; 133:5:1684-1692. Robinson J.P. Phagocyte Function: a Guide for Research and Clinical Evaluation // Eds. J.P. Robinson, G.F. Babcock. Wiley-Liss. Inc. New York. – 1998. – P. 217-252. Rosenson R.S., Tangney C.C. Antiatherothrombotic properties of statins – implications for cardiovascular event reduction. JAMA 1998; 279:1673-50. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801. Rotkiewicz P., Sicinska W., Kolinski A. and DeLuca H.F. (2001) Proteins, 44, 188-199. Rotta J.С.G., Lunardi C.N, Tedesco А. // Braz. J Med. Biol. Res. – 2003. – 36, N 5. – P. 587-594. Roubin G.S., Harris P.J., Eckhardt I. et al. Intravenous nitroglycerine in refractory unstable angina pectoris // Aust N Z J Med 1982; 12:598-602. Roxana Campisi, Johannes Czernin, Heiko Schoder, James W. Sayre, Fernando D. Marengo, Michael E. Phelps, Heinrich R. Schelbert Effects of Long-term Smoking on Myocardial Blood Flow, Coronary Vasomotion, and Vasodilator Capacity Circulation 1998; 98:119-125. Roxana Campisi, Johannes Czernin, Heiko Schoder, James W. Sayre, Heinrich R. Schelbert L-Arginine Normalizes Coronary Vasomotion in Long-Term Smokers Circulation. 1999; 99:491-497. Rubanyi G.M. (1993). The role of endothelium in cardiovas­cular homeostasis and diseases. J. Cardiovasc. Pharmacol., 22(Suppl. 4):1-4. Rubart M., Zipes D.P. Nitric oxide hope for patients with atrial fibrillation. Circulation 2002; 106:22:2764-2766. Rudd M.A., Freedman J.E., Loscalzo J. // J. Pharmacol. Experirn. Therap. – 1998. – 284, N 2. – P. 526-534. Sacks F.M., Preffer M.A., Moye L.A. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Reccurent Events Trial investigators. N Engl J Med 1996; 335:1001-1009. Sahin K., Stoeffler A., Fortuna P. еt al. Dementia severity and the magnitude of cognitive benifit by memantine treatment. A subgroup analysis of two placebo-controlled clinical trials in vascular dementia // Neurobiol.Aging. 2000. Vol. 21.P. S27. Sakai T., Ichiyama T., Whitten C.W., Giesecke A.H., Lipton J.M. Can J Anaesth – 2000 Oct; 47(10):1019-24 Related Articles, Books. Saletu B., Grunberger J., Linzmayer L. еt al. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2 weeks infusions with the hemoderivative Actovegin: double blind placebo controlled trials // Neuropsychobiol. 1990–1991. V.24. P. 135-145. Sanchez B., Lopez-Martin E., Segura C., Labandeira-Garcia J.L. and Perez-Fernandez R. (2002) Brain Res. Mol. Brain. Res., 108, 143-146. Sapirstein A., Bonventre J.V. Neurochem Res 2000 May; 25(5):745-53. Sapolsky R.M. Glucocorticoids, Stress and their Adverse Neurological Effects: Relevance to Aging // Experimental Gerontology. 1999; 34, Р. 721-732. Sarkar R., Meinberg E.G., Stanley J.С. et al. Nitric oxide reversibility inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 1996: 78: 225-230. Sauer D., Fagg G. (1992). Excitatory aminoacids, excitotoxicity and neurodegenerative disorders. In: P. Krogsgaard Larsen, J.J. Hansen (Eds.) Excitatory amino acid receptors: design of agonists and antagonists. Ellis Horwood, New York, pp. 13-34. Scandinavian Simvastatin Sunnval Study Investigators. Randomiseci trial cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Sinivastatin Survival Study (4S). Lancet, 1994; 344: 1383-1389. Scharfstein J.S., Keaney J.F.Jr., Slivka A. et al. // J. Clin. Invest. – 1994. – 94, N 4. – P. 1432-1439. Schechter A.N., Gladwin M.T. // N. Engl. J. Med. – 2003. – 348, N 15. – P. 1483-1485. Schimokawa H., Flawahan N.A., Vanhoute P.M. Loss of endothelial pertussis toxin sensitive G protein function in atherosclerotic porkine coronary arteries. Circulation 1991; 83:652-660. Schini V.B., Dewey J., Vanhoutte P.M. Related Effects of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries. Am J Cardiol 1990 May 2; 65(17):6H–10H. Schmidt H.H.H.W., Hofmann H., Schindler U. еt al. // Proc. Natl. Acad. Sci. USA. – 1996. –93, N 25. – P. 14492-14497. Schmidt H.H.H.W., Hofmann K, Ogilvie P. // The role of nitric oxide in physiology and pathophysiology. В.: Heidelberg: Springer. 1995. P. 75-86. Scholkens B.A., Unger T. ACE Inhibitors, Endothelial function and Atherosclerosis. Amsterdam Media Medica Publications. March 1993. Schultz E., Steuger E. Uberdasarginin. Z Physiol Chem 1886; 11:4365. Schulze-Neis, Penny D.J., Rigby M.L. et al. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation 1999:100:749-755. Schuman E.M., Madison D.V. // Annu. Rev. Neurosci. 1994. V. 17. P. 153-183. Semkova I., Krieglstein J. Brain Res Brain Res Rev 1999 Aug; 30(2): p.176-88. Semlitsch H.V., Anderer P., Saletu B., Hochmayer I. Topographic mapping of cognitive event-related potentials in double blind placebo controlled study with the hemoderivative Actovegin in age-associated memory impairment // Neuropsychobiol. 1990/91. Vol. 24. P. 49-56. Serruys P.W., Foley D.P., Jackson G. et al. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J 1999; 20:58-69. Sessa W.S., Prichard K., Seyedi N. et al. Chronic exercise in dogs increases coronary vascular NO production and endothelial NOS-gene expression. J Clin Investig 1992; 90:278-281. Shabanic M., Pulfer S.K. еt al. // Wound Repair regul. – 1996. – Vol. 4. – P. 353-362. Shah P.K. New insights inio the pathogenesis and prevention of acute coronary symptoms. Amer. J. Cardiol. 1997: 79: 17-23. Shah С.M., Locke I.С, Chowdrey H.S, Gordge M.P. I Biochem. Soc. Trans. – 2003. – 31, N 6. – P. 1450-1452. Shapira Y.J. Neurosur. Anesthesiol. –N4.-P.231-240-1992. Shapoval L.N., Sagach V.F., Pobegailo L.S. Nitric oxide influences ventrolateral medullary mechanism of vasomotor control in the cat// Neurosci Lett. – 1991. – 132. – P. 47-50. Sharon A., Shpirer I., Kaluski E. et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema // J Am Coll Cardiol 2000; 36:832-837. Shimaoka M., Iida T., Ohara A., Taenaka N., Mashimo T., Honda T., Yoshiya I. Br J Anaesth. – 1996 Aug; 77(2):238-42 Related Articles, Books. Shimoyama M., Shimoyama N., Gorman A.L., Elliott K.J., Inturrisi C.E. Pain. – 1999 May; 81(1-2):85-93 Related Articles, Books, Link Out. Shinpo K., Kikuchi S., Sasaki H., Moriwaka F., Tashiro K. (2000) J. Neurosci. Res., 62, 374-382. Shishido S.M., Seabra А.В., Loh W. de Oliveira M. G. I/ Biom. – 2003. – 24, N 20. – P. 3543-3553. Shmidt H.H.К.W., Hofmann R., Schindler U. еt al. I Proc. Natl. Acad. Sci. USA. 1996. 93. P. 14492-14497. Sibon I., Fenelon G., Quinn N.P., Tison F. Vascular parkinsonism // J. Neurol. 2004. Vol. 251. P. 513–524. Singh S., Evans T.W. Nitric oxide, the biological mediator of the decade: fact or fiction? // Eur. Respir. J. 1997. Vol.10. Vol. 699707. Slusher B.S., Vornov J.J., Thomas A.G., Hurn P.D., Harukuni I., Bhardwaj A., Traystman R.J., Robinson M.B., Britton P., Lu X., Tortella F.C., Wozniak K.M., Yudkoff M., Potter B.M., Jackson P.F. Nat Med 1999 Dec; 5(12): p1396-402. Small G.W. What we need to know about age related memory loss // Brit. Med. J. 2002. Vol. 324. P. 1502–1505. Smith S.L.; Hall E.D. J Neurotrauma 1998 Sep; 15(9): p707-719. Snyder S.H., Bredt D.S. // Scient. Amer. – 1992. – May. – P. 68-77. Sofroniew M.V., Howe C.L., Mobley W.C. Annu Rev Neurosci 2001; 24:1217-1281. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin С improves endothelial ctysfubction of epicardial coronary arteries in hypertensive patients. Circulation, 1997: 96: 1513-1519. Solzbach V., Hornig В., Jeserich M. et al. Vitamins С improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997; 96:1513-1519. Somers M.J., Harrison D.G. Reactive oxygen species and the control of vasomotor tone. Curr Hypertens Rep 1999; 1:102-108. Sorensen S.P.L. Uber die synthese des dl-arginins (a-amino-γ- guanidino-n-valeriansaure und der isomeren-γ-guanidino-a-n-amino-n-valeriansaure). Chem Ber 1910; 43:643-651. Sorrentino S., Landmesser U. Nonlipid-lowering Effects of Statins. Curr Treat Options Cardiovasc Med. 2005 Dec; 7(6):459-466. Sporl-Radun S., Betzein G., Kaufmann B. et al. Effect and pharmacokinetics of isosorbide dinitrate in normal man // Eur Clin J Pharmacol 1980;18:237-244. Squadrito G.L., Pryor W.A. // Free Radic. Biol. Med. – 1998. – 25, N 4-5. – P. 392-403. Stainton M.P. Simple, efficient reduction column for use in automated determination of nitrate in water // Analyt. Chem. – 1994. – Vol. 46, № 9. – P. 1616. Stamler J.S., Jaraki O., Osbome J. et al. // Proc. Natl. Acad. Sci. USA. – 1992. – 89, N 16. – P. 7674-7677. Stamler J.S., Singel D.J., Loscalzo J. // Science. – 1992. – 258, N 5090. – P. 1898-1902. Stamler J.S. Redox signaling: nitrosylation and related target interactions oi nitric oxide. Cell, 1994; 74: 931-938. Stamler J.S., Jia L., Eu J.P. et al // Science. – 1997. – 276, N 5321. – P. 2034-2037. Stampfer M.J., Colditz G.A., Willett W.C. et al Postmenopausal estrogen therapy and cardiovascular disease: ten–year follow-up from the Nurses’Health Study. N Engl J Med.1991; 325:756-762. St-Arnaud, R. (1999) Bone, 25, 127-129. Stefano G., Prevot V., Beauvillain J.C. et al. Cell-Surface Estrogen Receptors Mediate Calcium–Dependent Nitric Oxide Release in Human Endothelia. Circulation. 2000; 101:1594. Steinberg H.О., Chaker H., Leaning R. Obesity and insulin resistance are associated with endothelial dysfunction. Implication for the syndrome of insulin resistance. J Clin Invest 1996; 97:11:2601-2610. Steinberg О., Chaker H., Leaning R. Obesity and insulin resistance are associated with endothelial dysfunction. Implication for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610. Steinhorn R.N., Russell I.A., Morln F.C Pulmonary arteries from newborn lambs with persistent pulmonary hypertension have decreased sensitivity to nitric oxide. Pediat Res 1994; 35:354A. Stephens S., Kenny R.A., Rowan E. et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia // J. Amer. Ger. Soc. 2005. Vol. 53. № .1. P. 103-107. Stephens S., Sadler S., Rowan E. et al. Vascular mild cognitive impairment and cognitive impairment after stroke // Cerebrovascular Disease, Cognitive Impairment and Dementia. Second edition. Ed. By J.O’Brien et al. London, New York: Martin Dunitz, 2004. P. 225-236. Stephenson D., Rash K., Smalstig B., Roberts E., Johnstone E., Sharp J., Panetta J., Little S., Kramer R., Clemens J. Glia 1999 Aug;27(2):110-28. Sternberg E.M. Interactions between the immune and neuroendocrine systems. In: Mayer E.A., Saper C.B. Progress in Brain Research. Vol. 122. Elsevier Science. 2000; Р. 328-348. Stieg P.E., Sathi S., Warach S. et al. Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat // Eur. J. Pharmacol. 1999. Vol. 375. P. 115-120. Stoll M., Steckelings M., Paul M., Bottari S.R., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J.Clin. Invest.1995; 95: 651-657. Stroes E. Statins and LDL-cholesterol lowering: an overview. Curr Med Res Opin. 2005; 21 Suppl 6:S9-16. Stroes E.S., Koomans Н.А., de Bmin T.W.A., Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet, 1995; 346:467-471. Stuart J. Hutchison; Krishnankutty Sudhir; Richard E. Sievers; Bo-Qing Zhu;Yi-Ping Sun; Tony M. Chou; Kanu Chatterjee; Prakash C. Deedwania; John P. Cooke; Stanton A. Glantz; William W. Parmley Effects of L-Arginine on Atherogenesis and Endothelial Dysfunction due to Secondhand Smoke Hypertension 1999; 34:44-50. Stuhlinger M.C., Oka R.K., Graf E.E. et al. Endothelial dysfunction induced by hyperhomocysteinemia: role of asymmetric dimethylarginine. Circulation 2003; 108:933-938. Sugiama S., Okada Y., Sukhova G.K. et al. // Am. J. Pathol. 2001. Vol. 158. P. 879-891. Susie D., Francischetti A., Frohlich E.D. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats. Hypertension 1999; 33:451-455. Sussex B.A., Campbell N.R., Raju M.K., McKay D.W. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment // Clin Pharmacol Ther 1994; 56:229-234. Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R. and McLachlan D.R. (1992) Brain Res. Mol. Brain Res., 13, 239-250. Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy // Circulation 2000; 101:2981-2988. Swindell A.C., Valentine J.J. Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice. Am J Cardiol 1987 May 29; 59 (14):29G–34G. Taddei S., Virdis A., Ghiadoni L., Uleri S., Magagna A., Salvetti S. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 1997; 30:1606-1612. Taddei S., Virdis A., Mattel P. et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1296-1303. Takase H., Moreau P., Kung C.F., Nava E., Luscher T.F. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996; 27:25-31. Takenaka I., Ogata M., Koga K., Matsumoto T., Shigematsu A. Anesthesiology 1994 Feb; 80(2):402-8. Related Articles, Books. Takizawa S., Fujita H., Ogawa S. et al. Cerebr Blood Flow Metab., 1996, 16. – P.1075-1078. Takizawa T., Tada T., Kitazawa K., Tanaka Y., Hongo K., Kameko M., Uemura K.I. Neurol Res 2001 Oct; 23(7):724-730. Talman W.T. // Braz. J. Med. Biol. Res. – 1997. – ЗО, N 4. – P. 515-520. Tarry W.C., Makhoul R.G. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler. Thromb. 1994:14:938-943. Tawakol A., Ornland T., Gerhard M. et al. Hyperhomocysteinemia is associated with impaired enaothcliurn – dependent vasodilation function in humans. Circulation, 1997:95:1119-1121. Taylor T., Chasseaud L.F., Doyle E. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects // Biopharm Drugs Dispos 1980; 1:149-156. Teo K.K., Catellier D.J. Long-term nitrate use in chronic coronary artery disease: need for a randomized con-trolled trial // Am Heart J 1999; 138(3 Pt 1):400-402. Thadani U. Oral nitrates: more than symptomatic therapy in coronary heart disease? // Cardiovasc Drugs Ther 1977; 11:213-218. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial // Lancet 999; 353:9-13. The Multicenter Diltiazem Post-infarction Trial Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction // N Engl J Med 1988; 319:385-392. The Parkinson Study Group. Levodopa and the progression of Parkinson's disease // N Engl J Med. 2004. V. 351. P. 2498-2508. Thiel V.E., Audus K.L. Antioxid Redox Signal 2001 Apr; 3(2):273-278. Thomas D.D., Liu X., Kantrow S.P., Lancaster J.R.Jr. // Proc. Natl. Acad. Sci. USA. – 2001. – P. 355-360. Thomas Heitzer, Seppo Yla-Herttuala, Jukka Luoma, Sabine Kurz, Thomas Munzel, Hanjorg Just, Manfred Olschewski, Helmut Drexler Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia Role of Oxidized LDL Circulation 1996; 93:1346-1353. Thomas J.A. Protein S-thiolation, S-nitrosylation, and irreversible sulfhydryloxidation: roles in redox regulation / http: //www.bb.iastate.edu/~bb404/proteinoxidation.pdf. Thomson L., Trujillo M., Telleri R., Radi R. Kinetics of cytochrome oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide producing biological systems. Arch Biochem Biophys 1995; 319:491-497. Tien M., Berlett B.S., Levine R.L. еt al. // Biochemistry. – 1999. – 96, N 14. – P. 7809-7814. Tienfenhacher C.P., Chilian W.M., Mitchel M., DeFily D.V. Restoration of endothclium-dependent vasodilation after reperliision injury by tetrahydrobiopterin. Circulation, 1996: 94: 1423-1429. Ting H.H., Timimi F.K., Haley E.A., Roddy M.A. et al. Vitamin С improves endothelium-dependent vasodilation in forearm vessels of humans with hypercholes-terolemia. Circulation, 1997: 95: 2617-2622. Ting H.H., Timini F.K., Boles K.S. el al. Vitamin С improves enoothelium-dependent vasodilatiiin in patients with non-insulin-dependent diabetes mellitus. J. Clin. Investig. 1996: 97: 22-28. Tingberg E., Roijer A., Thilen U. et al. Randomized, double-blind, placebo-controlled long-term study of isosor-bide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction // Am Heart J. 2003; 145(1):E1. Tirilazad for acute ischaemic stroke (Cochrane Review). Cochrane Database Syst Rev 2001; 4:CD002087. Tohru Fukai, Martin R. Siegfried, Masuko Ushio-Fukai, Yian Cheng, Georg Kojda and David G. Harrison Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training J Clin Invest, June 2000, Volume 105, Number 11, 1631-1639. Tommasino C., Picozzi P. Minerva Anestesiol 1998 May; 64(5):225-227. Tomomi G., Masataka M. Nitric oxide and endoplasmic reticulum stress // Arteriosclerosis, Thrombosis and Vascular Biology. 2006; 26, Р. 1439. Tonkin A.M. Clinical relevance of statins: their role in secondary prevention. Atheroscler Suppl. 2001 Feb; 2(1):21-25. Topol E.J. Intensive statin therapy – a sea change in cardiovascular prevention. N Engl J Med. 2004 Apr 8; 350(15):1562-1564. Tousoulis D., Davies G.J., Tentolouris С. et al. Effect of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries. Heart 2003; 89:5:531-534. Touys R.M. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000; 2:98-105. Touzani O., Young A.R., MacKenzie E.T. (1994). In: Kriegistein J., Oberpichler-Schwenk H., eds. Pharmacology of Cerebral Ischaemia. Stuttgart: Medpharm, 575-588. Treasure C.B., Manoukian S.V., Klem J.L. еt al. Epicardial coronary artery response to acetylclioline are impared in hypertensive patients. Circ. Research 1992; 71: 776-781. Trischler H.J., Wolff S.P. Thioctic (Lipoic)-acid: A therapeutic metalchelating antioxidant? // Biochem.-Pharmacol. – 1995. –Vol. 15. – P. 320-333. Trujillo M., Alvarez M.K, Peluffo G. еt al // J. Biol. Chem. – 1998. – 273, N 14. – P. 7828-7834. Trujillo M., Radi R. //Arch. Biochem. Biophys. – 2002. – 397, N 1. – P. 91-98. Tsao P.S., Wang B., Buitrago R., Shyy J.Y., Cooke J.P. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997; 97: 934-940. Tschuggel W., Schneeberger C., Unfried G. еt al. Elevation of inducible nitric oxide synthase activity in human endometrium during menstruation // Biol. Reprod. – 1999. – Vol. 60, № 2. – P. 297-304. Tseng C.J., Liu H.J., Lin H.C. et al. Cardiovascular effects of nitric oxide in the stem nuclei of rats// Hypertension. – 1996. – 27. – P. 36-42. Tsikas D., Frolich J.С. I I Circ. Res. – 2002. – 90, N 3. – P. e39-e39. Turko I.V., Murad F. // Farmacol. Rev. – 2002. – 54, N 4. – P. 619-634. Tzeng E., Billiar T.R. // Arch. Surg. – 1997. – Vol. 132. –P. 977-982. Tzourio C., Andersen C., Chapman N. et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease // Arch Inern Med. 2003. V. 163. N. 9. P. 1069-1075. Uffelen B.E.V., Van der Zee J., Roster В.M. et al. // Biochem. J. – 1998. – 330, N 4. –P. 719-722. Ulfendahl H.R., Aurell M. Renin-Angiotensin/ Portland Press/ London. 1998. Р. 305. Ulker S., McKeown P.P., Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activity. Hypertension 2003; 41:3:534-539. Upchurh G.R., Welch G.N., Fabian A.J. et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272:17012-17017. Uribe R.M., Lee S., Rivier С. Endotoxin stimulates nitric oxide production in the paraventricular nucleus of the hypothalamus through nitric oxide synthase. Correlation with hypothalamo-pituitary-adrenal axis activation // Endocrinology. – 1999. – Vol. 140. – P. 5971-5981. Uzan M., Tanriover N., Bozkus H., Gumustas K., Guzel O., Kuday C. Surg Neurol 2001 Dec; 56(6):350-6. Vallence P., Coller J., Moncada S. Infects of endothelium-derived nitric oxide on peripheial arteriolar tone in man. Lancet. 1989; 2: 997-999. Van Boven A.J., Brugemann J., de Graeff P.A. et al. The 4S study. Implications for prescribing. Drugs. 1996 Apr; 51(4):507-14. Van de Werf F., Ardissino D., Betriu A. et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology // Eur Heart J 2003; 24:28-66. Van der Vliet A., Eiserich J.P., Cross С.E. // Respiratory Research. – 2000. –1. – P. 67-72. Van der Vliet A., Hoen P.A.C, Wong P.S.-Y. et al. II J. Biol. Chem. – 1998. – 273, N 46. – P. 30255-30262. Van Der Worp HB, Kappelle LJ, Algra A, Bar PR, Orgogozo JM, Ringelstein EB, Bath PM, van Gijn J. Neurology 2002 Jan 8; 58(1):133-135 Van Crevel. Clinical approach to dementia // In: Aging of the brain and Alzheimer’s disease. Ed. By D.F.Swab et al. Progress in brain research. Vol. 70. Amsterdam etc: Elsevier. 1986. P. 3-13. Vane J.R., Anggard E.E., Batting R.M. Regulatory functions of the vascular endotnelium. New England Journal of Medicine, 1990:323:27-36. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur Heart J 1997; 18:E19-E29. Vanhoutte P.M., Mombouli J.V. Vascular endothelium: vasoactive mediators. Prog. Cardiovase. Dis., 1996; 39:229-238. Vanin A.F., Muller В., Alencar J.L. еt al. // Current Topics in Biophysics. – 2002. – 26, N 1. – P. 101-113. Vaughan D.E., Rouleau J-L., Ridker P.M. et al. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation, 1997; 96:442-447. Vaughan D.E., Lazos S.A., Tong K. Angiotensin II regulates the expresiion of plasminogen activator inhibitor-1 in cultured endothelial cells. J. Clin. Invest. 1995; 95:995-1001. Vaughan D.E. Endothelial function, fibrinolysis, and angiotensyn-converting enzym inhibition. Clin. Cardiology. 1997; 20 (SII):II-34-II-37. Vereschagin E.I. Method of Brain Protection and treatment of Apallic Syndrome In: The Immune Consequences of Trauma, Shock and Sepsis. Munich, 2000. – P. 55-60. Vergnani L., Hatrik S., Rice F. Effect of native and oxidized LDL on nitric oxide and su-peroxide production: Key role of L-arginine availability. Circulation 2000; 101:l 1:1261-1266. Verheugt F.W.A. Acute coronary syndromes: drug treatments // Lancet 1999; 353 (suppl II):20-23. Villeneuve S., Belleville S., Gauthier S. The contribution of vascular risk factors and disease on the cognitive deficits of persons with mild cognitive impairment // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 78. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain// Neuroscience. – 1992. – 46. – P. 755-784. Vodovotz Y., Kim P.К.M., Bagci E.Z. еt al // Current Мої. Medicine. – 2004. – 4, N 7. – P. 753-762. Voevodskaya N. V., Serezhenkov V. А., Содper С. Е. еt al. // Biochem. J. –2002. – 368, N Pt 2. – P. 633-639. Vogel R.A., Coretti M.C., Ploinic G.D. Effect of single high-fat meal on endothelial hinction in healthy subject. Amer. J. Cardiol. 1997; 79:350-354. Vosatka R.J., Kashyar S., Trifiletti R.R. Arginins deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994; 66:65-70. Vrecer M., Turk S., Drinovec J., Mrhar A. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int J Clin Pharmacol Ther. 2003 Dec; 41(12):567-577. Wahlund L.O., Pihlstrand E., Eriksdotter Jonhagen M. Mild cognitive impairment: experience from a memory clinic // Acta Neurol. Scand. 2003. Vol. 107 (Suppl. 179). P. 21-24. Walbert T., Jirikowski G.F. and Prufer K. (2001) Horm. Metab. Res., 33, 525-531. Wali, R.K., Kong, J., Sitrin, M.D., Bisonette, M. and Li Y.C. (2003) J. Cell Biochem, 88, 794-801. Walz W., Cerebral Ischemia. Molecular and cellular pathophysiology // Humana Press. – Totowa, New Jersey. – 1999. – 290 р. Wancata J., Krautgartner M., Friedrich F. The numbers of vascular dementia in Europe between the years 2000 and 2050 // 2nd Congress of the International Society for Vascular Behavioural and Cognitive Disorders (Vas-Cog). Abstract book. Florence, 2005. P. 36-37. Wanchu A., Khullar M., Sud A., Bambery P. Elevated nitric oxide production in patients with primary Sjogren’s syndrome // Clin. Rheumatol. – 2000. – Vol. 19, № 5. – P. 360-364. Wang J.Y., Wu J.N., Cherng T.L., Hoffer B.J., Chen H.H., Borlongan C.V. and Wang Y. (2001) Brain Res., 904, 67-75. Wang, Y., Chiang Y.H., Su T.P., Hayashi T., Morales M., Hoffer B.J., and Lin S.Z. (2000) NeuroPharmacol., 39, 873-880. Wan-hua amy Yu, Spatial and Temporal Correlation of Nitric Oxide Synthase Expression with CuZn-Superoxide Dismutase Reduction in Motor Neurons following Axotomy. Ann NYAS 2002; 962:111-21. Wasterlain G.C., Sankar R.T. Excitotoxicity and the-developing brain // Epileptogenic and excitotoxic mechanisms / G. Avanzini et al., (eds.) – John Libbey. London; Paris; Rome, 1993. – P. 351-353. Watanabe G., Tamiama H., Doha N. Effects of oral administration, of L-arginine on renal function in patients with heart failure. J Hypertens 2000;35:706-713. Watts R.N., Richardson D.R. // Eur. J. Biochem. – 2002. – 269, N 14. – P. 3383-3392. Wendehenne D., Pugin A., Klessig D.F., Dumer J. // TRENDS in Plant Science. – 2001. – 6, N 4. – P. 177-183. Wennerblom B., Lurje L., Karlsson T. et al. Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients // Int J Cardiol 2001; 79(1):61-69. Wentzel C., Rockwood K., MacKnight C. et al. Progression of impairment in patients with vascular cognitive impairment without dementia // Neurology. 2001. Vol. 57. P. 714-716. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996 Nov 16;348(9038):1339-1342. Wever R., Boer P., Hijeniering M. Nitric oxide production is reduced in patients with chronic renal failure. Atherioscler Thromb Vase Biol 1999; 19:5:1168-1172. Whetsell W.O., Jr. Shapira N.A. (1993) Neuroexcitation, excitotoxicity and human neurological disease. Lab. Invest., 68(4): 372-387. Williams J.K., Adams M.R. Estrogens, progestins and coronary artery vasoreactivity. Certain progestins may oppose the favorable effects of estrogen on the cardiovascular system of post-menopausal women. Nature Med 1997; 3:273-274. Willix A.L., Nagel B., Churchill V. el al. Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits. Arteriosclerosis 1985:5:250-255. Wink D.A., Mitchell J.В. // Free Radic. Biol. Med. – 1998. – 25, N 4-5. – P. 434-456. Wink D.A., Vodovotz Y., Laval J. et al. // Carcinogenesis. – 1998. – 19, N 5-7. – P.I 1-721. Wl. Zhang Y., Hogg N. // Proc. Nat. Acad. Sci. –2004. – 101, N 21. – P. 7891-7896. Wong P.S., Hyun J., Fukuto J.M. et al. // Biochemistry. – 1998. – 37, N 16. – P. 5362-5367. Woods K.L. Commentary: biostatistics, biological mechanisms and Bayes: lessons from the magnesium trials // Int J Epidemiol 2002 Feb; 31(1):105-106. Wright В., Tai H., Dar J., Churg A. Cigarette smoke induces rapid changes in gene expression in pulmonary arteries. Labor Investig 2002; 82:10:1391-1398. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336:1-17. Wu G., Chen Y., Hazen S.L. //J. Biol. Chem. – 1999. – 274, N 36. – P. 25933-2544. www.marketing.vc по материалам «МеdLinks.ru» (статины). www.medicalprogress.org (иск. сосуды). www.provisor.com.ru (семакс). Xia Y., Zweier J.L. // Proc. Natl. Acad. Sci. USA. – 1997. – 94, N 23. – P. 12705-12710. Xia Y., Dawson V.L., Dawson T.M. et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular ingury. Proc Natl Acad Sci USA 1996;93:6770-6774. Xiu Q., Wang; Nosratola D. Vaziri Erythropoietin Depresses Nitric Oxide Synthase Expression by Human Endothelial Cells Hypertension. 1999; 33:894-899. Xu-Welliver M., Kanugula S., Pegg A.E. // Cancer Research. – 2002. – 62, N 11. – P. 3037-3043. Yallampalli С., DongY.L., Gangula P.R., Fang L. Role and regulation of nitric oxide in the uterus during pregnancy and parturition // J. Soc. Gynecol. Investig. – 1998. – Vol. 5, № 2. – P. 58-67. Yamashiro S., Naguchi K., Matsusaki T. et al. Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts. J Thorac Cardiovasc Surg 2002; 124:775-784. Yang J., Fukuo К., Morimoto S. et al. Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells Hypertension. 2000; 35:82. Yang Y., Li Q., Ahmad F., Shuaib A. Neurosci Lett 2000 May 12; 285(2): p. 119-22. Yaoxian Ding, Nosratola D. Vaziri Calcium Channel Blockade Enhances Nitric Oxide Synthase Expression by Cultured Endothelial Cells Hypertension. 1998; 32:718-723. Yasuda T., Takeshita H., Iida R., Nakajima T., Hosomi O., Nakashima Y., Kishi K. (1998) J. Biol. Chem. 273, 2610-2616. Yates D.H., Kharitonov S.A., Robbins R.A., Thomas P.S., Barnes P.J. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide // Ibid. 1995. Vol.152, № 3. P.892896. Yeates R.A Rela Influence of doxazosin on the activity of the endothelium-derived relaxing factor. Arzneimittelforschung 1994 Oct; 44(10):1117-21. Yukihito Higashi, Shota Sasaki, Satoshi Kurisu et al. Regular Aerobic Exercise Augments Endothelium–Dependent Vascular Relaxation in Normotensive As Well As Hypertensive Subjects Role of Endothelium–Derived Nitric Oxide Exercise Relaxation Circulation. 1999; 100:1194-1202. Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of randomised trials // Lancet 1988;1:1088-1092. Zamora R., Vodovotz V., Billiar T.R. Inducible nitric oxide synthase and inflammatory diseases // Molec. Med. 2000. Vol. 6, №5. Р. 347-373. Zanzinger J., Czachurski J., Seller H. Effects of nitric oxide on sympathetic baroreflex transmission in the nucleus tractus solitarii and caudal ventrolateral medulla in cats // Ibid. – 1995. – 197. – P. 199-202. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M. and Hewison M. (2001) J. Clin. Endocrinol. Metab., 86, 888-894. Zeiher A.M., Krause T., Schachinger V. et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995, 91: 2345-2352. Zeiher A.M., Schachinger V., Minnenf. Long-term cigarette smoking impairs endotheliu in-dependent coronary arterial vasodilator function. Circulation, 1995: 92: 1094-1100. Zeiker A.M., Fisslthaler В., Schray Utz B., Basse R. Nitric oxide modulates the expression of monocyte chemoat-tractant protein I in cultured human endothelial cells. Circ. Res. 1995; 76: 980-986. Zhang W., Smith C., Monette R., Hutchison J., Stanimirovic D.B. Acta Neurochir Suppl 2000; 76:47-53. Zhang X., Hintze T.H. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998; 97:576-580. Zhang Z., Naughton D., Winyard P.G. еt al. // Biochem. Biophys. Res. Commun. – 1998. – 249, N 3. – P. 767-772. Zhou Z., Rahme E., Pilote L. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Am Heart J. 2006 Feb;151(2):273-281. Zijlmans J.C.M., Katzenschlager R., Daniel S.E., Lees A.J.L. The L-dopa response in vascular parkinsonism // J. Neurol. Neurosurg. Psychiatry. 2004. Vol. 75. P. Zweier H., Samouilov A., Kuppusamy P. Non-enzymatic nitric oxide syuthesis in biological systems. Biochem Biophys Acta 1999; 1411:250-262. Zwoger R.H., Bode-Boger S.M., Mugge A. et al. Suplementation of hypercholesterolemic rabbits with L-arginine reduced the vascular release of syperoxide anion and restores NO production.Atherosclerosis 1995; 117:273-284. Наукове видання Малахов Володимир Олександрович, Завгородня Ганна Миколаївна, Личко Володимир Станіславович, Джанелідзе Тамуна Тимуразівна, Волох Федір Олександрович ^ ПРОБЛЕМА ОКСИДУ АЗОТУ В НЕВРОЛОГІЇ (російською мовою) Монографія Відповідальний за випуск В.О. Малахов Комп’ютерна верстка В.С. Личко Суми: Видавництво СумДПУ ім. А.С. Макаренка, 2009 р. Свідоцтво ДК № 231 від 02.11.2000 р. Здано в набір 10.05.09. Підписано до друку 10.06.09. Формат 60×84/16. Папір ксерокс. Гарн. Times. Друк ризогр. Умовн. друк. арк. 12,8. Обл. вид. арк. 14,1. Тираж 300. Вид. №42. Видавництво СумДПУ ім. А.С. Макаренка 40002, Суми, Роменська, 87

---

Ваша оценка:

Похожие:

	Роль оксида азота и цитокинов в развитии синдрома острого повреждения лёгких		Клиническое значение определения оксида азота в выдыхаемом воздухе при бронхиальной астме у детей
	Оксидативный стресс и система оксида азота при постнатальной адаптации и развитии заболеваний у сельскохозяйственных		Роль молекул оксида азота в программированной гибели нейтрофилов при окислительном стрессе 03. 00.
	Комбинированная фармакологическая коррекция метаболического пути l-аргинина/no при моделировании		Влияние электромагнитного излучения на частотах молекулярных спектров поглощения и излучения атмосферного
	Влияние электромагнитного излучения терагерцового диапазона на частотах молекулярного спектра излучения		Применение экзогенного оксида азота в комплексном лечении больных с воспалительными заболеваниями Работа выполнена в Московском областном научно-исследовательском клиническом институте им. М. Ф....
	Москва ■ Санкт-Петербург ■ Нижний Новгород ■ Воронеж Ростов-на-Дону ■ Екатеринбург ■ Самара ■ Новосибирск		Исследование проводилось на осушенных и вторично заболоченных торфяниках в пойме р. Га В последние годы все чаще и острее поднимается проблема изменения климата в следствие увеличения...

Разместите кнопку на своём сайте:
Медицина

---